Eating disorder

KRA_PSY_EATING

eating disorder: A broad group of psychological disorders with abnormal eating behaviors leading to physiological effects from overeating or insufficient food intake.

Suggest a new description

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — F50 Hospital discharge: ICD-9 — 3071\|3075[ABE] Hospital discharge: ICD-8 — 30650 Cause of death: ICD-10 — F50 Cause of death: ICD-9 — 3071\|3075[ABE] Cause of death: ICD-8 — 30650 2 out of 7 registries used, show all original rules.	4092
4. Check minimum number of events None	4092
5. Include endpoints None	4092
6. Filter based on genotype QC (FinnGen only)	4092

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

First used in FinnGen datafreeze: DF12
Parent code in ICD-10: F50-F59
Name in latin: Perturbationes edendi

NAME	KRA_PSY_EATING
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	F50
HD_ICD_9	3071\|3075[ABE]
HD_ICD_8	30650
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	F50
COD_ICD_9	3071\|3075[ABE]
COD_ICD_8	30650
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Eating disorder based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	4092	3753	339
Unadjusted period prevalence (%)	1.19	1.28	0.15
Median age at first event (years)	22.06	21.24	31.05

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
3680: Matched controls
36777

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

F50.8

ICD-10 Finland

Other eating disorders

413.4

323.0

567

F50.9

ICD-10 Finland

Eating disorder, unspecified

452.1

323.0

1608

F50.3

ICD-10 Finland

Atypical bulimia nervosa

384.4

323.0

659

N05AH04

ATC

quetiapine; oral

5.7

323.0

1601

4397

F32.9

ICD-10 Finland

Depressive episode, unspecified

5.0

323.0

1412

4045

F50.1

ICD-10 Finland

Atypical anorexia nervosa

942.4

323.0

812

F50.2

ICD-10 Finland

Bulimia nervosa

494.9

323.0

945

F50.0

ICD-10 Finland

Anorexia nervosa

1189.6

323.0

1093

N06AB03

ATC

fluoxetine; oral

10.8

323.0

1581

2404

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

6.6

316.7

924

1784

P86

ICPC

Anorexia nervosa/bulimia

59.4

280.6

331

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

4.8

260.9

1030

2764

N06AX16

ATC

venlafaxine; oral

4.4

254.5

1115

3310

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

4.2

249.0

1148

3565

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

7.0

241.4

650

1089

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

6.6

240.6

685

1239

N06AB06

ATC

sertraline; oral

4.4

227.8

987

2855

N05BA04

ATC

oxazepam; oral

3.5

226.4

1368

5275

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

5.6

225.9

736

1569

ZY010

NOMESCO Finland

Hospital outpatient

5.6

210.6

684

1443

N05AH03

ATC

olanzapine; systemic

6.0

201.0

609

1175

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

6.0

189.8

571

1087

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

6.9

189.7

512

844

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

3.5

187.5

1065

3803

N05AX12

ATC

aripiprazole; systemic

6.2

186.8

546

1001

N03AX09

ATC

lamotrigine; oral

5.5

183.8

595

1236

N06AX11

ATC

mirtazapine; oral

3.0

182.3

1455

6616

T36

ICD-10 Finland

Poisoning by systemic antibiotics

6.0

176.6

534

1018

N06AB04

ATC

citalopram; systemic

3.3

174.3

1066

3995

N05AX08

ATC

risperidone; systemic

5.7

172.9

544

1087

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

8.4

172.2

401

526

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

9.9

170.0

359

398

N06AB10

ATC

escitalopram; oral

2.9

166.8

1371

6265

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

6.2

161.1

467

839

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

4.5

157.9

622

1581

N06AX12

ATC

bupropion; oral

4.3

155.8

646

1725

N91.1

ICD-10 Finland

Secondary amenorrhoea

6.5

152.9

429

736

Z3226

NOMESCO Finland

Physiotherapist

3.3

146.2

870

3135

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

6.0

143.5

429

796

Z3231

NOMESCO Finland

Registered nurse

2.7

138.1

1192

5472

Z2445

NOMESCO Finland

Psychologist

4.8

136.1

495

1148

IBZ05

NOMESCO Finland

Evaluation of patient with eating disorder

1359.5

135.2

131

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

5.6

133.6

420

826

3071A

ICD-9 Finland

Special symptoms or syndromes not elsewhere classified, Anorexia nervosa

+∞

132.0

126

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

7.4

127.9

321

467

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

3.0

127.5

867

3392

Z2446

NOMESCO Finland

Social worker

4.3

126.4

516

1339

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

5.7

125.4

388

747

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

4.6

125.2

475

1146

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

3.0

124.6

889

3583

IGY99

NOMESCO Finland

Other psychiatric treatment contact

6.8

123.2

331

530

F60.9

ICD-10 Finland

Personality disorder, unspecified

10.2

120.0

247

258

N05CF01

ATC

zopiclone; oral

2.7

118.0

991

4401

E66.8

ICD-10 Finland

Other obesity

4.9

117.6

421

953

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

6.6

117.5

321

525

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

7.8

116.1

282

389

N03AG01

ATC

valproic acid; systemic, rectal

4.7

114.2

419

972

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

5.1

111.8

377

798

F50.4

ICD-10 Finland

Overeating associated with other psychological disturbances

232.9

110.3

113

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

4.8

109.6

396

903

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

4.6

108.3

404

952

ICC04

NOMESCO Finland

Psychiatric treatment plan, permanent discontinuation

6.5

105.7

290

476

R4190

NOMESCO Finland

Nutritional therapy

5.8

105.6

317

584

N05AA02

ATC

levomepromazine; systemic

6.9

104.1

275

428

F29

ICD-10 Finland

Unspecified nonorganic psychosis

4.9

104.1

364

800

IER01

NOMESCO Finland

Psychoeducation, group

16.5

102.5

168

106

N05AF03

ATC

chlorprothixene; systemic

8.2

99.8

232

298

F61.0

ICD-10 Finland

Mixed personality disorders

8.4

99.1

228

288

F34.1

ICD-10 Finland

Dysthymia

5.0

97.1

332

710

F50

ICD-10 Finland

Eating disorders

90.9

95.5

106

N05BA01

ATC

diazepam; systemic, rectal

3.3

95.1

535

1794

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

7.8

94.3

226

304

F33.00

ICD-10 Finland

Recurrent depression, mild episode without somatic syndrome

6.1

94.2

272

476

N05BA06

ATC

lorazepam; systemic, sublingual

6.7

93.8

251

397

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

4.2

91.9

384

1004

F41.1

ICD-10 Finland

Generalized anxiety disorder

3.3

91.9

523

1766

Z2221

NOMESCO Finland

Medical doctor

2.2

91.5

1242

6903

T05

ICPC

Feeding problem of adult

10.7

90.8

181

177

N03AX16

ATC

pregabalin; oral

2.7

90.4

739

3161

P76

ICPC

Depressive disorder

3.1

89.0

562

2037

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

6.2

88.9

252

430

N06AX05

ATC

trazodone; oral

6.8

87.4

230

355

P01

ICPC

Feeling anxious/nervous/tense

2.2

84.2

1075

5762

P29

ICPC

Psychological sympt/compl other

3.0

84.0

557

2084

N06AX21

ATC

duloxetine; oral

3.1

83.8

526

1896

N06AB05

ATC

paroxetine; oral

3.9

83.6

374

1037

C07AA05

ATC

propranolol; systemic

2.3

82.9

965

4947

R63.0

ICD-10 Finland

Anorexia

34.7

82.8

108

F50.5

ICD-10 Finland

Vomiting associated with other psychological disturbances

217.3

82.7

ZYC01

NOMESCO Finland

Remote contact by phone

4.2

82.6

338

864

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

2.6

82.1

697

3029

ZXY51

NOMESCO Finland

2-person team, doctor-nurse

6.4

81.4

225

371

N05AN01

ATC

lithium; oral

6.2

81.3

229

387

N05CD07

ATC

temazepam; oral

4.7

80.2

292

665

30650

ICD-8 Finland

Special symptoms not elsewhere classified, Feeding disturbance

+∞

79.4

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.4

78.4

818

3959

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

4.2

78.1

318

808

N06AX03

ATC

mianserin; oral

6.0

77.5

226

399

F33.1

ICD-10 Finland

Recurrent depressive disorder, current episode moderate

4.2

76.9

313

794

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

6.1

75.4

215

369

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

5.0

74.0

253

538

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

4.6

73.6

271

623

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

3.8

73.2

330

918

IGY02

NOMESCO Finland

Psychiatric monitoring contact

4.6

73.0

270

623

F33.4

ICD-10 Finland

Recurrent depressive disorder, currently in remission

4.5

73.0

274

642

F32.1

ICD-10 Finland

Moderate depressive episode

2.9

72.7

483

1798

N05BE01

ATC

buspirone; oral

6.6

72.5

194

306

N05AB03

ATC

perphenazine; systemic, rectal

5.7

72.3

220

409

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

7.5

70.7

174

243

RD210

NOMESCO Finland

6.2

70.3

199

338

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

5.4

69.7

220

427

F93.89

ICD-10 Finland

Other childhood emotional disorders

5.7

69.0

209

386

F33.30

ICD-10 Finland

Recurrent depression, severe episode without somatic syndrome

9.7

68.1

142

151

G03DB01

ATC

dydrogesterone; oral

2.3

68.1

712

3421

F31.8

ICD-10 Finland

Other bipolar affective disorders

5.1

66.3

219

448

IFA01

NOMESCO Finland

Psychiatric pharmacotherapy plan, not specified

5.7

66.1

200

369

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

6.8

66.1

174

268

SPAT1240

SPAT

Therapeutic discussion

2.2

66.1

841

4421

P03

ICPC

Feeling depressed

2.2

65.6

795

4086

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

4.9

64.6

222

474

F99

ICD-10 Finland

Mental disorder, not otherwise specified

5.1

64.2

215

446

N06AX26

ATC

vortioxetine; oral

3.0

63.6

405

1457

R63.4

ICD-10 Finland

Abnormal weight loss

6.3

63.4

176

291

T08

ICPC

Weight loss

7.6

63.4

154

211

N05CF02

ATC

zolpidem; oral

2.4

63.3

640

3010

F40.1

ICD-10 Finland

Social phobias

3.8

62.7

281

775

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

4.5

62.5

236

555

ZY000

NOMESCO Finland

Hospital inpatient

6.6

61.3

164

258

N05AH02

ATC

clozapine; systemic

6.1

60.4

171

290

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

7.0

58.1

149

221

N03AX11

ATC

topiramate; oral

4.4

57.8

222

531

IBA01

NOMESCO Finland

Diagnostic and symptom-mapping evaluation

4.6

56.6

208

476

AA400

NOMESCO Finland

Electroconvulsive therapy

9.8

56.5

117

123

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

5.7

56.4

169

308

N05BA12

ATC

alprazolam; oral

2.9

56.3

367

1339

P74

ICPC

Anxiety disorder/anxiety state

2.9

56.1

383

1439

IER03

NOMESCO Finland

Psychiatric disorder-specific group intervention

17.5

56.0

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.8

56.0

1569

10897

R4140

NOMESCO Finland

Psychotherapy

8.6

55.5

124

149

E66.01

ICD-10 Finland

Obesity due to excess calories

2.5

55.3

468

1994

E87.6

ICD-10 Finland

Hypokalaemia

8.2

54.7

126

159

N06AB08

ATC

fluvoxamine; oral

6.6

54.0

144

226

T82

ICPC

Obesity

3.7

53.9

248

698

F43.1

ICD-10 Finland

Post-traumatic stress disorder

3.4

53.8

281

876

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

4.1

53.6

219

555

N03AE01

ATC

clonazepam; systemic

3.9

53.4

231

616

N07BB01

ATC

disulfiram; oral

4.6

53.1

192

432

SPAT1307

SPAT

Psychosocial counselling and guidance

2.1

52.8

665

3440

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

3.1

52.5

308

1043

E66.9

ICD-10 Finland

Obesity, unspecified

3.7

52.5

240

672

IER04

NOMESCO Finland

Rehabilitative psychiatric group intervention, functional

8.4

52.3

118

144

IBA04

NOMESCO Finland

Extensive initial psychiatric evaluation

4.6

51.7

189

430

IER02

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, group

8.5

51.6

116

141

ICB03

NOMESCO Finland

Psychiatric treatment plan, monitoring

5.1

51.4

169

343

P99

ICPC

Psychological disorders other

3.8

50.9

225

612

G47.3

ICD-10 Finland

Sleep apnoea

2.4

50.4

461

2043

F32

ICD-10 Finland

Depressive episode

2.7

49.8

380

1521

Z3229

NOMESCO Finland

Other healthcare associate professional

3.0

48.2

303

1076

R4110

NOMESCO Finland

Physiotherapy

2.0

48.1

762

4305

SPAT1139

SPAT

Nutrition survey

4.1

47.7

194

489

A02BC02

ATC

pantoprazole; systemic

1.7

47.6

1789

13320

SPAT1298

SPAT

Other function in accordance with nutritional therapy nomenclature

7.2

47.5

119

171

ZXY60

NOMESCO Finland

2-person team, nurses

8.5

46.1

103

124

K03.21

ICD-10 Finland

Erosion of teeth due to: persistent vomiting

33.8

46.1

N06AA12

ATC

doxepin; systemic

4.8

45.4

159

346

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

5.3

44.8

142

277

IDY03

NOMESCO Finland

Systematic individual therapy, cognitive-behavioural

2.9

44.8

287

1030

N06AG02

ATC

moclobemide; oral

4.5

44.2

163

374

R53

ICD-10 Finland

Malaise and fatigue

1.9

44.2

821

4898

E66.00

ICD-10 Finland

Metabolic syndrome

4.1

43.6

179

455

XF400

NOMESCO Finland

ECG with 12 standard connections

2.4

43.5

401

1778

ZXE01

NOMESCO Finland

Procedure duration 0 to 9 minutes

5.0

42.9

143

295

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

3.0

42.9

264

923

H03AA01

ATC

levothyroxine sodium; systemic

1.9

42.2

773

4582

F33

ICD-10 Finland

Recurrent depressive disorder

3.8

41.8

185

503

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

2.5

41.7

351

1483

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.8

41.6

954

6086

A04

ICPC

Weakness/tiredness general

1.9

41.2

655

3679

P11

ICPC

Eating problem in child

21.7

40.9

F42.2

ICD-10 Finland

Mixed obsessional thoughts and acts

5.9

40.7

118

207

E66

ICD-10 Finland

Obesity

3.2

40.5

222

715

N02AX02

ATC

tramadol; systemic, rectal

1.7

40.3

1003

6549

RF220

NOMESCO Finland

7.9

40.2

122

F39

ICD-10 Finland

Unspecified mood [affective] disorder

3.8

40.2

179

489

A06AC01

ATC

ispaghula (psylla seeds); oral

2.0

40.2

617

3421

A06AD11

ATC

lactulose; oral

2.6

39.8

324

1341

X78

ICD-10 Finland

Intentional self-harm by sharp object

6.7

39.7

104

160

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

2.6

39.3

320

1323

F33.8

ICD-10 Finland

Other recurrent depressive disorders

6.6

39.2

103

159

AA1AD

NOMESCO Finland

CT of head and brain

2.1

38.3

461

2312

ICB02

NOMESCO Finland

Psychiatric treatment plan, extended/prolonged

5.2

38.3

123

244

F31.1

ICD-10 Finland

Bipolar affective disorder, current episode manic without psychotic symptoms

8.7

38.2

F10.20

ICD-10 Finland

Alcohol dependence currently independent

6.4

38.0

102

162

F31

ICD-10 Finland

Bipolar affective disorder

5.5

38.0

115

213

F42.1

ICD-10 Finland

Predominantly compulsive acts [obsessional rituals]

6.3

37.8

103

167

ZXY01

NOMESCO Finland

Chief Physician, Head of Department or Deputy Chief Physician

6.5

37.4

100

158

N06AX22

ATC

agomelatine; oral

3.9

37.3

162

434

F60.5

ICD-10 Finland

Anankastic personality disorder

5.7

37.1

110

199

Z71.8

ICD-10 Finland

Other specified counselling

1.7

37.0

1086

7398

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.7

37.0

900

5807

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.8

36.0

755

4647

F31.31

ICD-10 Finland

Bipolar disorder depressive episode with somatic syndrome

10.5

36.0

G03FB06

ATC

medroxyprogesterone and estrogen; systemic (progestogens and estrogens, sequential prep.)

4.0

35.9

150

388

N05AD01

ATC

haloperidol; systemic

5.1

35.9

116

232

N06AX18

ATC

reboxetine; oral

11.0

35.8

F25.9

ICD-10 Finland

Schizoaffective disorder, unspecified

6.4

35.7

153

ZXE10

NOMESCO Finland

More than one and less than three hours

1.7

35.6

999

6709

Z03.2

ICD-10 Finland

Observation for suspected mental and behavioural disorders

4.1

35.6

144

362

3075A

ICD-9 Finland

Special symptoms or syndromes not elsewhere classified, Other and unspecified disorders of eating[TARKEMMIN MÄÄRITTELEMÄTÖN SYÖMISHÄIRIÖ]

+∞

35.5

103

Kela drug reimbursment

Diabetes, insulin-treated

2.1

35.4

436

2205

F20.9

ICD-10 Finland

Schizophrenia, unspecified

5.1

35.2

115

233

R5599

NOMESCO Finland

Other rehabilitation service

4.0

35.2

145

371

F42.9

ICD-10 Finland

Obsessive-compulsive disorder, unspecified

6.9

34.9

132

215

Kela drug reimbursment

Diabetes, non-insulin-treated

2.1

34.7

422

2117

ZXE20

NOMESCO Finland

More than three and less than five hours

2.3

33.8

347

1613

JDF11

NOMESCO Finland

Laparoscopic gastric bypass

5.2

33.7

107

210

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.9

33.4

213

760

N06AA06

ATC

trimipramine; systemic

5.2

33.2

105

205

F31.5

ICD-10 Finland

Bipolar affective disorder, current episode severe depression with psychotic symptoms

9.5

33.2

N06CA01

ATC

amitriptyline and psycholeptics; systemic

2.5

33.0

269

1110

IEY01

NOMESCO Finland

Psychoeducation, individual

5.4

32.7

100

188

IBZ02

NOMESCO Finland

Somatic assessment of psychiatric patient

8.9

32.5

F41.3

ICD-10 Finland

Other mixed anxiety disorders

3.7

32.4

149

419

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

2.0

32.3

430

2239

3075B

ICD-9 Finland

Special symptoms or syndromes not elsewhere classified, Other and unspecified disorders of eating[AHMIMISHÄIRIÖ]

+∞

32.3

IFB01

NOMESCO Finland

Electroconvulsive Therapy (ECT)

7.5

32.3

104

N05AE04

ATC

ziprasidone; systemic

6.3

32.2

140

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

2.1

32.2

385

1918

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

2.5

32.0

270

1137

F41.00

ICD-10 Finland

Moderate panic disorder

3.5

31.8

152

441

A02BC01

ATC

omeprazole; systemic

1.7

31.7

746

4734

F90.0

ICD-10 Finland

Disturbance of activity and attention

2.4

31.7

276

1181

N06AA09

ATC

amitriptyline; systemic

2.7

31.1

228

886

L17

ICPC

Foot/toe symptom/complaint

1.7

31.0

823

5403

N04AA02

ATC

biperiden; systemic

5.7

30.9

164

M79.6

ICD-10 Finland

Pain in limb

1.6

30.8

1094

7756

F31.3

ICD-10 Finland

Bipolar affective disorder, current episode mild or moderate depression

5.7

30.6

158

F60.6

ICD-10 Finland

Anxious [avoidant] personality disorder

7.8

30.4

R07.4

ICD-10 Finland

Chest pain, unspecified

1.8

30.4

542

3145

ZXY49

NOMESCO Finland

Other health care provider

7.9

30.3

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

4.9

30.3

102

214

F32.8

ICD-10 Finland

Other depressive episodes

3.9

30.1

129

342

C03CA01

ATC

furosemide; systemic

2.2

30.1

315

1476

R11

ICD-10 Finland

Nausea and vomiting

2.1

30.1

352

1735

N06BA04

ATC

methylphenidate; oral

2.7

29.9

220

857

K59.09

ICD-10 Finland

Constipation, unspecified

3.1

29.8

169

557

A10BA02

ATC

metformin; oral

1.9

29.8

451

2466

IDR02

NOMESCO Finland

Systematic group therapy, cognitive

34.9

29.6

IFA99

NOMESCO Finland

Other psychiatric pharmacotherapy service

7.0

29.5

108

S18

ICPC

Laceration/cut

1.6

29.3

1062

7551

F45.8

ICD-10 Finland

Other somatoform disorders

2.0

29.2

430

2324

P06

ICPC

Sleep disturbance

2.0

29.1

431

2338

IGV01

NOMESCO Finland

Psychiatric network contact

5.1

29.1

189

K59.0

ICD-10 Finland

Constipation

2.8

29.0

193

709

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

4.1

29.0

115

285

LC2AE

NOMESCO Finland

Ultrasound examination of uterus and parametria

1.8

28.3

573

3458

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

3.9

28.3

119

311

ZXE17

NOMESCO Finland

Procedure duration 150 to 179 minutes

5.0

28.2

191

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.5

28.2

1336

10083

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.5

28.1

1238

9190

IBA03

NOMESCO Finland

Psychotherapy evaluation

4.4

28.0

103

237

ZXE00

NOMESCO Finland

One hour or less

1.5

28.0

1346

10184

F41.09

ICD-10 Finland

UNS Panic Syndrome

2.5

28.0

223

911

R51.80

ICD-10 Finland

Headache

1.7

27.9

701

4512

D01

ICPC

Abdominal pain/cramps general

1.7

27.9

598

3673

T90

ICPC

Diabetes non-insulin dependent

2.2

27.9

310

1493

ZXD10

NOMESCO Finland

Scheduled procedure

1.5

27.6

1062

7634

F51.0

ICD-10 Finland

Nonorganic insomnia

1.8

27.3

577

3528

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.7

27.3

711

4622

R42

ICD-10 Finland

Dizziness and giddiness

1.8

27.2

537

3215

E11

ICD-10 Finland

Type 2 diabetes mellitus

2.6

27.0

211

852

F60.8

ICD-10 Finland

Other specific personality disorders

6.1

27.0

126

R02

ICPC

Shortness of breath/dyspnoea

1.9

26.9

401

2176

SPAT1234

SPAT

Support of social functional capacity

3.2

26.6

145

467

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.9

26.3

443

2511

N05AF01

ATC

flupentixol; systemic

7.6

26.3

X59

ICD-10 Finland

Exposure to unspecified factor

1.7

25.9

586

3656

ZXY82

NOMESCO Finland

Nurse in multidisciplinary team

6.3

25.7

111

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

6.1

25.6

119

RT230

NOMESCO Finland

20.2

25.6

F41.8

ICD-10 Finland

Other specified anxiety disorders

2.5

25.6

211

878

R1100

NOMESCO Finland

General evaluation of the need for rehabilitation

3.7

25.5

113

309

R06.0

ICD-10 Finland

Dyspnoea

1.7

25.5

621

3953

L03

ICPC

Low back symptom/complaint

1.6

25.5

883

6170

Z50.4

ICD-10 Finland

Psychotherapy, not elsewhere classified

8.3

25.3

SPAT1389

SPAT

Visit based on need for special support

2.1

25.2

293

1436

IEV99

NOMESCO Finland

Other psychiatric network intervention

5.9

25.2

122

IGP01

NOMESCO Finland

Psychiatric family contact

4.7

25.1

189

R4120

NOMESCO Finland

Occupational therapy

2.5

25.1

199

810

F60.0

ICD-10 Finland

Paranoid personality disorder

10.3

25.0

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.2

24.9

270

1282

ZXY59

NOMESCO Finland

2-person team, nurse-other special worker

11.0

24.8

F44.9

ICD-10 Finland

Dissociative [conversion] disorder, unspecified

5.4

24.7

141

N03AX12

ATC

gabapentin; oral

1.9

24.7

373

2032

WX110

NOMESCO Finland

Local anesthesy

1.5

24.6

2635

23203

F10.09

ICD-10 Finland

Alcohol intoxication UNS

3.8

24.6

106

284

C07AB07

ATC

bisoprolol; oral

1.6

24.3

696

4625

IEY08

NOMESCO Finland

Psychiatric coaching, domestic and community skills

10.1

24.2

R56.8

ICD-10 Finland

Other and unspecified convulsions

2.4

24.0

211

908

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.4

24.0

1587

12702

S51.9

ICD-10 Finland

Open wound of forearm, part unspecified

5.8

24.0

118

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

2.6

23.9

182

725

A02BC05

ATC

esomeprazole; systemic

1.5

23.9

975

7061

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.5

23.8

1111

8277

P72

ICPC

Schizophrenia

4.5

23.6

188

N39.4

ICD-10 Finland

Other specified urinary incontinence

2.7

23.5

168

645

IEY21

NOMESCO Finland

Other intensified psychiatric treatment

7.2

23.5

X84

ICD-10 Finland

Intentional self-harm by unspecified means

8.0

23.4

N02AJ06

ATC

codeine and paracetamol; systemic

1.5

23.4

1147

8631

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

2.2

23.4

238

1101

IBB02

NOMESCO Finland

Psychiatric evaluation of working capacity and rehabilitation

5.1

23.3

147

N05AA01

ATC

chlorpromazine; systemic, rectal

6.6

23.2

E66.0

ICD-10 Finland

Obesity due to excess calories

7.3

23.2

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.3

23.2

218

969

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

4.5

23.1

192

WX002

NOMESCO Finland

Sedation and analgesia

1.8

23.1

431

2524

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.8

23.1

471

2835

F25.10

ICD-10 Finland

Schizoaffective syndrome, depressive type with only concomitant bipolar and schizophrenic symptoms

6.7

23.1

Z01.8

ICD-10 Finland

Other specified special examinations

1.6

23.1

611

3972

F20.30

ICD-10 Finland

Undifferentiated schizophrenia continuous

4.8

23.0

162

P15

ICPC

Chronic alcohol abuse

3.7

22.9

101

276

F31.20

ICD-10 Finland

Bipolar disorder, manic episode with mood-congruent psychotic symptoms

6.5

22.9

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.8

22.8

455

2722

O99.3

ICD-10 Finland

Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium

2.6

22.7

171

677

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

2.1

22.7

275

1371

A28

ICPC

Limited function/disability NOS

2.5

22.7

192

808

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

2.0

22.6

290

1482

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

2.5

22.6

189

792

R5140

NOMESCO Finland

Monitoring the use of the aid

2.4

22.3

191

811

310

Kela drug reimbursment

Orlistat, sibutramine and other major and expensive medicines used to treat obesity

12.2

22.2

L28

ICPC

Limited function/disability (L)

2.0

22.2

293

1515

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.5

22.2

1177

8978

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.4

22.2

1889

15758

XF600

NOMESCO Finland

Bloodpressure measurement

2.4

22.1

198

860

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.4

22.1

1814

15022

RS210

NOMESCO Finland

8.4

21.8

TPH04

NOMESCO Finland

Cathetrisation of vein

1.7

21.7

500

3120

N06AA04

ATC

clomipramine; systemic

5.1

21.6

138

F10.24

ICD-10 Finland

Alcohol depence active use

5.7

21.5

110

SHB00

NOMESCO Finland

Prepation and fitting of bite rail to mouth

1.7

21.5

543

3478

WX722

NOMESCO Finland

PEEP

4.1

21.4

212

N05BA02

ATC

chlordiazepoxide; systemic

5.3

21.4

127

R1220

NOMESCO Finland

Psychological examination of need and possibilities to rehabilitation

4.1

21.3

213

160

Kela drug reimbursment

exenatide

6.4

21.2

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

4.7

21.2

159

J45.9

ICD-10 Finland

Asthma, unspecified

1.6

20.8

533

3427

ZXY81

NOMESCO Finland

Psychologist in multidisciplinary team

8.9

20.8

ICC01

NOMESCO Finland

Psychiatric treatment plan, transfer to psychiatric outpatient clinic

4.6

20.7

158

IAB01

NOMESCO Finland

Psychiatric pharmacotherapy consultation

5.9

20.6

100

J01FF01

ATC

clindamycin; systemic

1.5

20.6

742

5190

UJF30

NOMESCO Finland

Ileoscopy through colon

2.1

20.6

253

1268

L01

ICPC

Neck symptom/complaint

1.7

20.6

514

3276

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

2.7

20.6

147

565

R55

ICD-10 Finland

Syncope and collapse

2.0

20.6

260

1321

G44.2

ICD-10 Finland

Tension-type headache

1.6

20.5

524

3366

F61

ICD-10 Finland

Mixed and other personality disorders

7.8

20.5

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.6

20.5

564

3695

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.6

20.5

622

4177

F21

ICD-10 Finland

Schizotypal disorder

6.8

20.3

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.4

20.2

1176

9092

ZXY56

NOMESCO Finland

2-person team, nurse-psychologist

7.9

20.2

D11

ICPC

Diarrhoea

1.6

20.2

546

3560

2968A

ICD-9 Finland

Affective psychoses, Manic-depressive psychosis, other and unspecified

11.0

20.1

F19.20

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances currently independent

7.7

20.0

3018X

ICD-9 Finland

Personality disorders, Other personality disorders[MUU TAI SEKAMUOTOINEN PERSOONALLISUUSHÄIRIÖ]

20.9

19.9

D64.9

ICD-10 Finland

Anaemia, unspecified

2.4

19.9

166

696

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.6

19.8

588

3921

F42.0

ICD-10 Finland

Predominantly obsessional thoughts or ruminations

4.4

19.8

166

K03.2

ICD-10 Finland

Erosion of teeth

3.1

19.8

108

350

N05AE05

ATC

lurasidone; oral

7.1

19.8

A10BJ06

ATC

semaglutide; parenteral

4.0

19.6

201

S29

ICPC

Skin symptom/complaint other

1.6

19.5

517

3349

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

2.6

19.5

143

556

D12

ICPC

Constipation

3.2

19.5

103

326

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

2.5

19.5

154

627

G03FB08

ATC

dydrogesterone and estrogen; systemic (progestogens and estrogens, sequential prep.)

2.6

19.5

144

565

A03FA02

ATC

cisapride; oral, rectal

2.4

19.4

166

706

WX892

NOMESCO Finland

Monitored bed care

2.3

19.3

177

779

WYA10

NOMESCO Finland

First aid or other corresponding healthcare contact

1.8

19.3

366

2149

SAA01

NOMESCO Finland

Simple examination of mouth

1.4

19.2

2757

24891

A46

ICD-10 Finland

Erysipelas

2.2

19.1

208

992

IDR03

NOMESCO Finland

Systematic group therapy, dialectical behaviour therapy (DBT)

6.7

19.0

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.7

19.0

450

2824

M79.1

ICD-10 Finland

Myalgia

1.7

18.9

474

3022

R52.2

ICD-10 Finland

Other chronic pain

2.9

18.9

115

401

IER05

NOMESCO Finland

Rehabilitative psychiatric group intervention, social skills

10.7

18.9

A10BJ02

ATC

liraglutide; parenteral

4.9

18.8

129

N05AL01

ATC

sulpiride; systemic

5.4

18.8

104

Z73.8

ICD-10 Finland

Other problems related to life-management difficulty

4.9

18.8

125

188

Kela drug reimbursment

Psychosis requiring demanding treatment

6.8

18.7

N30.0

ICD-10 Finland

Acute cystitis

1.6

18.7

534

3522

RS214

NOMESCO Finland

8.0

18.7

A01

ICPC

Pain general/multiple sites

2.0

18.7

249

1289

F25.20

ICD-10 Finland

Schizoaffective syndrome, mixed type with only concomitant bipolar and schizophrenic symptoms

7.1

18.5

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

2.3

18.5

171

754

SPAT1148

SPAT

Treatment of chronic ulcer or burn

2.0

18.5

233

1181

N05AD03

ATC

melperone; systemic

8.1

18.4

SPAT1215

SPAT

Assessment of need for medical rehabilitation

2.3

18.4

168

737

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.8

18.4

343

2004

M54.5

ICD-10 Finland

Low back pain

1.4

18.4

1052

8075

IBA02

NOMESCO Finland

Evaluation of need for psychiatric rehabilitation

4.6

18.3

142

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

5.1

18.3

112

P01AB01

ATC

metronidazole; oral, rectal

1.4

18.3

1224

9666

E0000UV

ATC

1.4

18.2

1427

11580

W0A12

NOMESCO Finland

Planned therapy visit for psychiatric disease

4.9

18.2

125

Z72.2

ICD-10 Finland

Drug use

5.7

18.2

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.5

18.2

759

5468

N02BE01

ATC

paracetamol; systemic, rectal

1.4

18.2

2708

24447

UJF32

NOMESCO Finland

Coloscopy

1.6

18.2

464

2970

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

3.7

18.2

225

S76

ICPC

Skin infection other

2.5

18.2

146

601

E86

ICD-10 Finland

Volume depletion

4.8

18.1

126

SPAT1243

SPAT

Psychiatric/psychological examination

2.1

17.9

211

1041

E950A

ICD-9 Finland

Suicide and self-inflicted poisoning by solid or liquid substances

7.4

17.9

P80

ICPC

Personality disorder

5.3

17.8

103

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

2.2

17.8

194

925

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.0

17.7

227

1158

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

2.2

17.7

177

814

A10AE04

ATC

insulin glargine; parenteral

2.1

17.7

196

943

F98.9

ICD-10 Finland

Unspecified behavioural and emotional disorders with onset usually occurring in childhood and adolescence

5.3

17.6

104

TLC00

NOMESCO Finland

Insertion of intrauterine device

1.7

17.6

351

2090

A08AB01

ATC

orlistat; oral

14.6

17.6

3018D

ICD-9 Finland

Personality disorders, Other personality disorders[EPÄVAKAA PERSOONALLISUUS]

11.5

17.5

Z63.7

ICD-10 Finland

Other stressful life events affecting family and household

2.8

17.3

113

413

IAB07

NOMESCO Finland

Consultation concerning a patient with self-harm intention

5.8

17.3

N17

ICPC

Vertigo/dizziness

1.8

17.3

326

1907

A10BH01

ATC

sitagliptin; oral

2.8

17.3

114

418

A03FA01

ATC

metoclopramide; systemic, rectal

1.6

17.2

534

3590

S06.0

ICD-10 Finland

Concussion

1.7

17.2

379

2327

F12.1

ICD-10 Finland

Mental and behavioural disorders due to use of cannabinoids, harmful use

6.8

17.2

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.7

17.1

394

2449

P18

ICPC

Medication abuse

5.9

17.0

T50.9

ICD-10 Finland

Poisoning: Other and unspecified drugs, medicaments and biological substances

5.9

17.0

L08

ICPC

Shoulder symptom/complaint

1.7

17.0

414

2616

A02BC03

ATC

lansoprazole; oral

1.5

17.0

556

3788

R00.0

ICD-10 Finland

Tachycardia, unspecified

2.3

17.0

159

708

Z01.7

ICD-10 Finland

Laboratory examination

1.7

17.0

342

2046

ZXA05

NOMESCO Finland

Left side

1.6

16.9

441

2839

F19.9

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, unspecified mental and behavioural disorder

17.4

16.9

A02BA02

ATC

ranitidine; systemic

1.7

16.9

333

1980

S97

ICPC

Chronic ulcer skin

3.2

16.8

272

ZXD31

NOMESCO Finland

Major difficulties in performing procedure

2.4

16.7

145

619

F40.01

ICD-10 Finland

Agoraphobia with concomitant panic disorder

4.3

16.7

142

ICC03

NOMESCO Finland

Psychiatric treatment plan, transfer to psychiatric ward

5.6

16.7

RD112

NOMESCO Finland

8.8

16.6

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.5

16.6

550

3754

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.6

16.6

523

3529

F33.01

ICD-10 Finland

Recurrent depression, mild episode of somatic syndrome

6.1

16.6

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.5

16.6

540

3675

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

1.4

16.6

831

6201

RS220

NOMESCO Finland

3.7

16.5

202

S51.7

ICD-10 Finland

Multiple open wounds of forearm

6.2

16.5

X61

ICD-10 Finland

Intentional self-poisoning by and exposure to antiepileptic, sedative-hypnotic, antiparkinsonism and psychotropic drugs, not elsewhere classified

13.4

16.4

F60.7

ICD-10 Finland

Dependent personality disorder

8.6

16.4

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.7

16.4

343

2076

N91.0

ICD-10 Finland

Primary amenorrhoea

5.6

16.3

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.3

16.2

2034

17667

SHA02

NOMESCO Finland

Correction of physiology of bite - basic therapy visit

1.7

16.2

340

2058

F13.29

ICD-10 Finland

Addiction caused by sedative and hypnotic UNS

10.4

16.1

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.2

16.1

164

760

IBB01

NOMESCO Finland

Psychiatric functioning capacity evaluation

9.2

16.1

Z72.8

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1001

2551

4.86

307.65

6.0

5.7

mmol/l

1.1

5.63

927

2408

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

795

1813

5.19

307.65

3.1

2.6

g/l

0.2

0.53

724

1699

(3015377) Calcium [Moles/volume] in Serum or Plasma

1760

7910

3.14

269.12

2.8

2.6

mmol/l

2.3

1.14

1574

7150

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1922

9294

3.01

254.62

2.2

1.6

pmol/l

97.4

98.5

0.45

1113

5239

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

2284

12712

2.80

223.29

2.9

2.2

nmol/l

71.2

71.1

0.07

2120

11918

(3019309) Folate [Moles/volume] in Red Blood Cells

960

3347

3.44

218.69

1.9

1.6

nmol/l

1156.8

1166.5

0.11

772

2604

(3012095) Magnesium [Moles/volume] in Serum or Plasma

934

3217

3.46

216.75

3.8

3.6

mmol/l

0.8

1.14

873

3019

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

2062

11038

2.75

215.27

7.1

5.3

mmol/l

1.2

0.16

1779

9347

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1907

9862

2.74

212.45

6.5

4.8

mmol/l

1.2

1.56

1762

8996

(3024561) Albumin [Mass/volume] in Serum or Plasma

1895

9817

2.73

209.67

4.8

4.3

g/l

37.8

37.2

5.14

1752

9139

(3021960) Folate [Moles/volume] in Serum or Plasma

1188

5039

2.91

190.14

1.7

1.4

nmol/l

21.7

20.4

2.45

1077

4523

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

1194

5120

2.88

186.80

2.2

1.6

1.4

1.3

11.04

1062

4655

(3018418) pH of Serum or Plasma

1345

6350

2.66

172.33

3.9

3.2

7.4

0.88

230

1218

(3028707) Methadone [Presence] in Urine by Screen method

557

1582

3.91

170.23

3.2

2.5

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1484

7885

2.38

142.35

2.6

2.1

mg/l

2.7

2.6

0.52

1264

6793

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1751

10165

2.26

134.45

3.6

2.9

u/l

28.3

27.9

0.15

1653

9716

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

2920

20932

2.37

132.90

7.2

5.9

u/l

71.7

0.00

2747

19647

(3011288) Drugs identified in Urine by Screen method

680

2609

2.92

125.93

3.6

2.6

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

830

3586

2.65

121.99

2.3

2.2

mmol/l

2.4

0.52

707

3078

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1448

8320

2.14

108.54

3.2

2.3

u/l

57.9

55.0

2.01

1300

7703

(3044889) 12 lead EKG panel

2440

16995

2.08

108.47

3.6

2.4

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

3521

28419

2.70

108.31

5.8

4.1

pmol/l

13.8

14.2

25.42

3292

26306

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1741

10800

2.06

105.65

1.6

1.4

u/ml

1.0

1.5

2.61

455

3006

(3036481) Cortisol [Moles/volume] in Serum or Plasma

725

3151

2.58

103.86

2.0

nmol/l

396.3

389.2

0.39

651

2901

(3009508) Creatinine [Moles/volume] in Urine

1225

6701

2.18

103.23

3.7

3.3

mmol/l

7.4

8.2

4.46

1031

5918

(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma

186

334

5.78

98.93

13.5

11.1

mmol/l

0.6

0.66

173

308

(3001122) Ferritin [Mass/volume] in Serum or Plasma

2766

20649

2.04

95.60

3.8

2.9

ug/l

53.7

57.2

0.91

2601

19583

(3019550) Sodium [Moles/volume] in Serum or Plasma

3675

30836

2.87

94.62

15.4

8.2

mmol/l

139.3

139.4

2.70

3589

29763

(3023103) Potassium [Moles/volume] in Serum or Plasma

3679

30887

2.88

94.61

15.5

8.3

mmol/l

3.9

0.48

3583

29722

(3013650) Neutrophils [#/volume] in Blood by Automated count

2532

18405

1.98

93.37

11.3

7.5

e9/l

3.8

4.0

6.10

2203

16197

(1001926) Buprenorphine [Presence] in Urine by Screen method

661

2890

2.53

92.74

3.0

2.0

—

(42870588) Differential panel, method unspecified - Blood

1608

10036

1.99

92.70

6.4

5.8

—

(3006315) Basophils [#/volume] in Blood

2287

16093

1.95

92.41

7.0

5.6

e9/l

0.0

2.12

1981

14197

(3001604) Monocytes [#/volume] in Blood

2279

16045

1.94

91.63

7.0

5.6

e9/l

0.5

6.37

1978

14189

(3013115) Eosinophils [#/volume] in Blood

2345

16699

1.94

90.77

7.8

5.8

e9/l

0.2

5.91

2075

15001

(3019198) Lymphocytes [#/volume] in Blood

2359

16891

1.93

89.14

6.9

5.5

e9/l

1.9

2.0

4.99

2094

15262

(3013826) Glucose [Moles/volume] in Serum or Plasma

2288

16228

1.93

88.86

5.4

3.9

mmol/l

6.0

6.1

0.37

2101

14060

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1934

12989

1.92

88.56

4.9

4.7

umol/l

9.4

9.6

0.35

1764

12063

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

3735

31903

2.94

87.07

6.9

4.7

mu/l

1.7

1.9

1.65

3577

30321

(3022096) Basophils/100 leukocytes in Blood

2086

14556

1.88

83.01

7.2

5.7

0.7

0.6

0.66

1937

13607

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

918

4863

2.14

81.20

1.8

1.5

pmol/l

435.3

39301216.4

4.73

794

4262

(3019069) Monocytes/100 leukocytes in Blood

2154

15266

1.86

80.78

7.3

5.7

7.8

0.60

2018

14390

(3006504) Eosinophils/100 leukocytes in Blood

2142

15163

1.86

80.55

7.0

5.5

2.6

2.7

2.38

1992

14168

(3007164) IgA [Mass/volume] in Serum or Plasma

1448

9056

1.92

80.16

1.5

1.4

g/l

1.9

2.0

0.81

811

5721

(3014576) Chloride [Moles/volume] in Serum or Plasma

503

2066

2.63

79.62

7.1

6.5

mmol/l

104.6

105.2

2.29

495

2022

(3016879) Cocaine [Presence] in Urine

708

3414

2.30

78.82

3.1

1.9

—

(3022948) Iron [Moles/volume] in Serum or Plasma

784

3944

2.22

78.78

2.5

2.1

umol/l

14.0

14.7

1.70

730

3656

(3002030) Lymphocytes/100 leukocytes in Blood

2230

16140

1.84

76.51

7.0

5.4

30.8

30.5

0.84

2093

15179

(3000764) Benzodiazepines [Presence] in Urine

740

3700

2.22

75.17

3.1

1.9

—

(3018010) Neutrophils/100 leukocytes in Blood

2203

15943

1.82

75.02

6.9

5.3

55.4

56.0

1.61

2068

15041

(3028300) Cannabinoids [Presence] in Urine

741

3733

2.20

73.75

3.1

1.9

—

(3013707) Erythrocyte sedimentation rate by Westergren method

2902

22937

1.91

73.60

4.0

3.5

mm/h

9.1

8.6

1.74

2715

21438

(3009466) Valproate [Moles/volume] in Serum or Plasma

174

384

4.68

73.09

6.0

5.6

umol/l

369.1

370.6

0.03

144

330

(3027008) Opiates [Presence] in Urine

735

3723

2.18

72.01

3.1

1.8

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

3395

28421

2.13

71.61

4.4

2.9

mmol/l

5.6

5.5

2.89

3174

26669

(3021447) Carbon dioxide [Partial pressure] in Venous blood

441

1786

2.64

71.49

6.0

4.5

kpa

6.0

5.8

4.57

433

1722

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1038

5994

1.98

71.28

2.4

2.0

u/l

234.5

156.2

0.39

988

5683

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

114

177

6.59

70.10

4.5

3.5

umol/l

180.2

0.00

(3004789) Transferrin [Mass/volume] in Serum or Plasma

700

3525

2.19

69.38

2.5

2.1

g/l

2.5

0.13

634

3248

(3002032) Base excess in Venous blood by calculation

432

1771

2.61

68.20

6.2

4.5

mmol/l

1.7

1.5

0.52

358

1398

(40758558) Short blood count panel - Blood

1202

7458

1.86

65.48

7.3

5.9

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

3370

28502

2.03

63.52

11.4

7.1

ml/min/173m2

101.1

99.7

3.26

2647

22255

(3033658) Prothrombin time (PT) actual/Normal

1071

6472

1.88

62.99

4.4

3.4

97.1

97.2

0.05

1036

6257

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

626

3128

2.18

62.80

2.6

2.2

21.9

23.9

2.95

550

2707

(3027944) Amphetamines [Presence] in Urine

698

3679

2.08

60.78

3.0

1.8

—

(3021589) Normoblasts [#/volume] in Blood

2013

14766

1.71

60.14

9.9

7.5

e9/l

0.0

1.35

1612

12179

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

2859

23154

1.77

59.06

3.9

2.6

u/l

29.3

29.5

0.10

2702

22189

(3024354) Oxygen [Partial pressure] in Venous blood

372

1528

2.57

58.19

5.4

4.1

kpa

4.7

4.8

0.06

363

1474

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

3831

34432

2.74

57.14

10.8

7.4

u/l

24.3

23.7

0.49

3717

33339

(3008295) Osmolality of Serum or Plasma

112

214

5.35

55.61

3.7

1.8

mosm/kgh2o

284.2

287.2

0.99

174

(3021387) Prolactin [Units/volume] in Serum or Plasma

658

3513

2.04

54.87

1.8

1.6

mu/l

358.3

324.7

0.99

570

3125

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

300

1146

2.74

54.17

7.1

5.0

mmol/l

24.2

23.9

0.97

276

1051

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

184

532

3.57

53.46

1.9

2.1

—

(3000991) Gas panel - Venous blood

378

1632

2.45

53.04

9.9

8.0

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

373

1605

2.45

52.72

7.9

6.5

mmol/l

1.2

1.3

0.95

351

1530

(3048689) Calprotectin [Mass/mass] in Stool

958

5888

1.82

51.88

2.5

ug/g

82.0

98.3

1.00

709

4553

(44816559) Phosphatidylethanol [Mass/volume] in Blood

243

865

2.92

50.02

1.3

1.2

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

505

2523

2.14

49.99

2.7

2.2

u/l

31.6

54.8

0.64

428

2134

(3000570) Elastase.pancreatic [Mass/mass] in Stool

190

606

3.24

47.26

1.3

ug/g

318.8

325.8

0.13

274

(40768797) Stomach Pathology biopsy report

601

3272

1.98

46.88

1.2

—

(3027945) Reticulocytes/100 erythrocytes in Blood

415

1987

2.21

45.56

3.3

3.0

1.6

0.09

347

1774

(3009214) Lutropin [Units/volume] in Serum or Plasma

445

2191

2.15

45.54

1.7

1.4

u/l

7.4

9.2

2.84

354

1815

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

312

1332

2.45

44.68

4.8

3.9

kpa

5.2

5.1

3.68

293

1257

(3013512) EKG study

867

5399

1.77

43.96

3.2

2.4

—

(3009343) pH of Capillary blood

308

1320

2.44

43.72

4.8

3.9

7.4

1.17

157

(36660697) Celiac disease serology panel - Serum

662

3825

1.87

42.89

1.3

1.2

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

312

1382

2.36

41.09

1.7

1.6

nmol/l

0.3

0.5

9.12

251

1170

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

298

1295

2.40

40.97

4.9

3.9

mmol/l

1.5

1.1

1.44

206

890

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

2864

24173

1.61

40.76

5.0

3.6

mmol/mol

37.4

36.5

4.47

2666

22892

(3023368) Bacteria identified in Blood by Culture

844

5330

1.73

40.31

4.5

3.5

—

(3030467) Casts [#/volume] in Urine by Automated count

1115

7585

1.64

40.19

3.3

2.6

e6/l

0.2

0.3

0.60

806

5511

(4198724)

129

359

3.67

39.68

3.0

2.4

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

116

6.03

39.25

1.9

nmol/l

153.3

157.5

0.12

102

(3026782) Osmolality of Urine

835

5327

1.71

38.20

2.9

2.4

mosm/kgh2o

518.5

552.3

3.30

701

4523

(36304419) Bacteria [Presence] in Urine

1117

7705

1.62

37.62

3.3

2.6

—

(3002582) Erythrocytes [#/volume] in Urine

1194

8382

1.60

37.32

3.5

2.7

e6/l

131.9

101.2

0.16

883

6181

(3018095) Leukocytes [#/volume] in Urine

1485

10969

1.55

37.14

4.1

3.1

e6/l

67.0

72.3

0.13

947

6835

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1071

7359

1.61

36.46

3.0

2.4

ng/l

25.3

30.1

0.29

437

2560

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

492

2712

1.92

36.46

2.9

3.4

pmol/l

4.3

4.7

14.40

428

2453

(3020779) Urea [Moles/volume] in Serum or Plasma

324

1558

2.17

34.93

7.6

7.3

mmol/l

6.2

6.3

0.14

311

1503

(3004119) Hemoglobin [Mass/volume] in Venous blood

234

980

2.47

34.82

5.7

3.6

g/l

128.3

131.2

1.33

228

960

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

3718

34114

1.97

34.15

14.0

9.2

mg/l

18.2

18.8

0.60

2815

25848

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

664

4113

1.73

33.36

3.0

2.4

e6/l

4.7

5.1

0.38

313

2075

(3042936) Bacteria identified in Isolate by Culture

577

3433

1.79

33.35

2.0

1.8

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

326

1601

2.12

33.26

1.9

1.6

—

(3037467) Urinalysis macro (dipstick) panel - Urine

2825

24227

1.53

33.20

4.7

3.8

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

914

6171

1.62

32.94

1.7

1.5

mmol/l

1.3

1.02

799

5456

(3003396) Base excess in Arterial blood by calculation

337

1688

2.08

32.63

7.3

7.6

mmol/l

0.8

0.5

0.58

270

1217

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

512

2961

1.83

32.46

2.6

2.7

umol/l

5.8

0.00

405

2431

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

544

3205

1.80

32.44

3.0

2.7

ng/l

982.3

553.4

0.49

417

2508

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

587

3552

1.76

31.93

1.8

1.7

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

288

1373

2.18

31.68

4.1

3.8

ng/l

75.9

68.3

0.62

256

1261

(3027801) Oxygen [Partial pressure] in Arterial blood

333

1689

2.06

31.14

7.4

7.5

kpa

12.8

14.2

3.78

318

1610

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

333

1689

2.06

31.14

7.4

7.5

kpa

5.2

5.0

4.74

319

1606

(3016502) Oxygen saturation in Arterial blood

296

1443

2.13

30.74

7.6

8.2

95.3

96.6

1.67

288

1381

(3032080) INR in Blood by Coagulation assay

1073

7634

1.55

30.50

5.7

4.4

inr

1.1

0.34

381

2817

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

186

747

2.56

30.23

6.2

3.4

0.6

0.7

0.76

181

723

(3019225) pH of Specimen

374

2004

1.95

29.92

4.5

2.9

—

(3052851) Hemolysis interference index of Serum or Plasma

182

728

2.57

29.83

2.9

2.6

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

3255

29074

1.58

29.34

3.9

3.1

mmol/l

2.7

2.8

14.50

3031

27540

(3020191) Ethanol [Moles/volume] in Serum or Plasma

102

298

3.48

29.21

1.7

1.5

promille

1.1

1.3

1.11

231

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

185

754

2.52

29.16

8.7

9.6

mmol/l

24.4

23.9

1.10

170

720

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

670

4303

1.66

29.08

2.8

2.3

e6/l

1.0

1.2

0.51

321

2270

(3006653) Thiamine [Moles/volume] in Blood

122

4.97

27.84

1.3

1.6

nmol/l

137.5

129.0

0.56

122

(3002385) Erythrocyte distribution width [Ratio]

3381

30585

1.60

27.59

19.2

11.0

13.3

0.10

3326

29966

(3023323) Follitropin [Units/volume] in Serum or Plasma

552

3417

1.71

27.41

1.6

1.4

iu/l

15.4

18.3

1.74

448

2890

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

632

4055

1.66

27.40

2.0

1.9

—

(3022313) Gas panel - Capillary blood

213

952

2.30

27.37

5.4

4.4

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

3230

28940

1.54

27.26

3.8

2.9

mmol/l

4.6

4.7

9.76

3048

27625

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

1748

13969

1.44

26.96

2.8

2.4

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

348

1887

1.92

26.80

1.1

u/ml

0.9

5.0

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

131

468

2.86

26.78

2.9

2.7

mmol/l

24.3

23.8

0.71

114

427

(3031040) Bacteria [#/volume] in Urine by Automated count

2745

23852

1.45

26.49

5.1

3.8

e6/l

242.4

1473.5

3.27

264

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

1608

12692

1.44

26.35

2.6

2.2

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

226

1052

2.21

26.34

1.6

1.5

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

397

2261

1.83

26.22

1.7

1.6

—

(3000850) Epithelial cells [#/volume] in Urine

837

5802

1.55

26.16

2.8

2.3

e6/l

9.3

9.7

0.27

727

5010

(3024928) Oxygen saturation in Venous blood

114

382

3.04

26.14

7.2

4.2

—

(3007853) Bacteria identified in Skin by Aerobe culture

569

3594

1.68

26.12

2.0

1.6

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

3088

27508

1.49

25.78

3.4

2.7

mmol/l

1.2

1.1

1.41

2873

26248

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

992

7184

1.50

25.14

2.3

1.8

mg/l

0.9

0.30

664

5116

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

386

2208

1.82

25.10

1.7

1.6

—

(3037522) Nuclear Ab [Titer] in Serum

730

4951

1.58

25.00

1.4

titre

428.7

577.2

1.55

113

963

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

3197

28755

1.51

24.77

3.7

2.9

mmol/l

1.5

1.11

2992

27396

(3012516) Albumin [Mass/volume] in Urine

662

4399

1.60

24.71

3.8

3.5

mg/l

364.5

363.9

0.00

427

3004

(3020682) Albumin/Creatinine [Ratio] in Urine

680

4551

1.59

24.62

4.7

4.3

mg/mmol

10.7

13.6

0.69

438

3154

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

315

1700

1.92

24.57

3.6

2.7

mmol/l

1.2

0.43

270

1440

(3026008) Bacteria identified in Urine by Culture

1293

9903

1.44

24.48

2.8

2.2

—

(3019150) Specific gravity of Urine by Refractometry

1041

7659

1.48

24.26

3.7

3.1

kg/l

1.0

1.07

126

1187

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

417

2515

1.73

22.55

6.8

4.2

—

(3000494) Fungus identified in Specimen by Culture

500

3168

1.66

22.49

1.5

1.4

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

193

911

2.17

21.73

5.9

4.4

mmol/l

24.4

24.3

0.18

188

872

(1616796) Gas panel - Central venous blood

124

483

2.61

21.51

3.3

2.7

—

(3023520) Reticulocytes [#/volume] in Blood

252

1323

1.96

21.29

3.1

2.8

e9/l

67.8

70.2

0.43

167

943

(3042517) Benzodiazepines panel - Urine

5.22

20.74

2.1

2.2

—

(3020961) Endomysium IgA Ab [Titer] in Serum

410

2527

1.69

20.42

1.2

titre

20.8

199.8

—

(3022145) Colonoscopy Study observation

439

2765

1.66

20.11

1.3

—

(3003327) Ova and parasites identified in Stool by Light microscopy

286

1607

1.84

19.63

1.9

1.7

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

205

1031

2.04

19.56

2.1

2.2

ug/l

5.3

0.00

173

897

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

602

4114

1.54

19.53

1.3

iu/ml

91.4

158.3

4.96

173

1586

(3018677) aPTT in Platelet poor plasma by Coagulation assay

502

3292

1.60

19.51

3.7

2.4

29.6

29.3

0.60

479

3179

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

466

3007

1.62

19.35

1.1

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

534

3564

1.57

19.23

3.5

2.6

ng/l

403.2

328.8

0.10

236

1565

(3023511) Choriogonadotropin [Units/volume] in Urine

489

3201

1.60

19.13

1.5

1.4

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

811

5920

1.46

19.03

2.6

2.3

u/l

6520.6

6794.2

0.08

289

2423

(3017143) Hepatitis C virus Ab [Presence] in Serum

942

7104

1.42

18.45

1.9

1.6

—

(40761511) CBC panel - Blood by Automated count

3825

36360

1.78

18.27

14.0

8.5

—

(3028626) Oxygen [Partial pressure] in Capillary blood

146

662

2.25

18.18

6.4

5.0

kpa

9.2

9.4

0.80

134

628

(3014765) Yersinia sp identified in Stool by Organism specific culture

201

1042

1.97

17.63

1.2

1.1

—

(3003181) Sodium [Moles/volume] in Urine

205

3.25

17.29

2.2

1.6

mmol/l

64.2

71.1

0.41

180

(3023183) Ammonium ion [Moles/volume] in Plasma

374

2.63

17.24

2.7

2.9

umol/l

30.9

31.8

0.11

328

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

290

1702

1.76

17.18

1.6

1.5

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

322

1946

1.71

17.18

1.6

mg/l

3.5

4.0

0.49

237

1275

(42529406) Shigella sp [Presence] in Stool by Culture

200

1050

1.95

16.91

1.2

1.1

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

165

814

2.07

16.62

9.1

10.1

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

814

6081

1.42

16.59

1.4

1.3

iu/ml

66.0

21.3

0.43

197

1723

(3011397) Hemoglobin [Presence] in Urine by Test strip

1005

7797

1.38

16.38

3.5

3.1

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

127

569

2.27

16.31

1.9

2.2

ug/l

216.9

266.6

0.21

102

485

(3013139) Helicobacter pylori Ag [Presence] in Stool

343

2138

1.66

16.28

1.2

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

196

1036

1.93

16.26

1.2

1.1

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

393

2.53

16.10

2.4

2.3

nmol/l

21.3

24.6

2.07

377

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

182

942

1.97

16.05

2.3

2.1

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

213

1163

1.87

16.01

1.7

1.6

—

(3019060) Gas panel - Arterial blood

174

888

2.00

15.97

4.5

5.4

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

770

5762

1.41

15.42

1.3

u/ml

14.7

8.2

0.42

258

2422

(3022217) INR in Platelet poor plasma by Coagulation assay

280

1680

1.71

15.33

12.9

9.2

inr

1.1

0.02

315

(40767503) Oxygen content in Capillary blood by calculation

405

2.45

15.13

3.1

2.2

17.2

17.0

0.18

196

(3017446) Testosterone [Moles/volume] in Serum or Plasma

250

1459

1.76

15.11

1.9

1.7

nmol/l

6.3

6.1

0.10

208

1274

(3020717) Zinc [Moles/volume] in Serum or Plasma

228

2.97

15.09

1.7

1.6

umol/l

20.3

23.1

0.35

219

(3010421) pH of Blood

122

559

2.22

14.87

4.3

2.7

7.4

1.26

104

477

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

1173

9458

1.33

14.59

2.5

2.0

—

(3026493) Urate [Moles/volume] in Serum or Plasma

753

5681

1.40

14.27

2.2

umol/l

2090.0

2871.4

0.37

654

5104

(3012501) Base excess in Blood by calculation

108

482

2.27

14.05

4.2

2.7

mmol/l

2.2

1.9

0.21

250

(40760892) CBC W Ordered Manual Differential panel - Blood

1068

8546

1.34

13.87

4.8

3.8

—

(3021901) Oxygen saturation in Capillary blood

308

2.59

13.81

2.9

2.4

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

956

7540

1.35

13.65

2.2

1.8

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

4.33

13.54

1.1

1.2

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

196

1100

1.82

13.53

1.5

1.4

u/l

13.3

16.2

1.02

171

946

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

5.60

12.86

5.1

7.5

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

253

1550

1.67

12.83

1.6

1.5

—

(3035637) Corticotropin [Mass/volume] in Plasma

424

2.29

12.83

1.6

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

237

1439

1.68

12.44

1.1

u/ml

4.7

4.8

0.02

222

(3016244) Insulin [Units/volume] in Serum or Plasma

443

2.24

12.41

3.6

3.2

mu/l

29.2

29.1

0.01

414

(3035350) Ketones [Presence] in Urine by Test strip

1991

17509

1.26

12.03

3.7

3.1

estimate

0.0

1.15

384

3716

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

105

498

2.14

11.82

1.2

—

(3020891) Body temperature

121

606

2.02

11.79

6.3

4.4

—

(3005719) IgG [Mass/volume] in Serum or Plasma

347

2340

1.53

11.76

2.2

2.6

g/l

9.9

10.5

3.59

315

2164

(3007461) Platelets [#/volume] in Blood

3988

38822

2.02

11.66

23.9

13.7

e9/l

268.0

267.5

0.20

3924

37987

(3028026) IgM [Mass/volume] in Serum or Plasma

274

1760

1.59

11.51

1.6

1.7

g/l

1.2

1.4

3.37

253

1645

(3009261) Glucose [Presence] in Urine by Test strip

1999

17662

1.26

11.33

3.8

3.1

estimate

0.0

0.25

390

3778

(3021601) Nitrite [Presence] in Urine by Test strip

1986

17553

1.25

11.15

5.1

4.2

estimate

0.0

1.34

399

3846

(3026361) Erythrocytes [#/volume] in Blood

3989

38874

1.99

11.01

23.9

13.6

e12/l

4.4

4.5

13.06

3914

38004

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

5.73

10.98

1.1

mg/l

48.6

47.7

—

(3024731) MCV [Entitic volume]

3988

38865

1.98

10.94

23.8

13.6

89.8

89.3

8.41

3960

38462

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

357

2.29

10.93

1.4

1.6

g/l

0.0

0.03

339

(3035941) MCH [Entitic mass]

3988

38867

1.98

10.91

23.8

13.6

29.9

29.8

1.24

3960

38463

(3009542) Hematocrit [Volume Fraction] of Blood

3575

34044

1.39

10.66

17.2

9.8

39.2

39.6

4.47

2916

28576

(3010813) Leukocytes [#/volume] in Blood

3988

38889

1.95

10.54

24.0

13.7

e9/l

6.6

6.9

16.18

3916

37991

(3007566) Smooth muscle Ab [Titer] in Serum

142

784

1.84

10.41

1.2

1.4

titre

47.1

103.0

2.73

(3000963) Hemoglobin [Mass/volume] in Blood

3988

38899

1.94

10.38

24.1

13.7

g/l

131.5

133.2

16.61

3960

38493

(3025941) Bacteria identified in Stool by Culture

337

2319

1.49

10.36

1.2

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

166

962

1.75

10.35

2.3

2.9

ng/l

58.5

100.1

2.84

135

818

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

335

2303

1.49

10.35

3.4

2.3

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

282

1869

1.54

10.35

1.5

1.4

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

1932

17120

1.24

10.26

2.5

2.1

—

(21494755) Public health laboratory ask at order entry panel

373

5171

0.69

10.20

1.2

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

141

789

1.81

9.91

2.2

2.3

g/l

1.2

0.32

121

689

(3021879) Hepatitis B virus core Ab [Presence] in Serum

574

4379

1.36

9.89

1.6

1.5

—

(3011648) Oxygen content in Venous blood

151

2.93

9.88

2.6

5.9

10.9

11.3

0.27

151

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

146

2.96

9.84

1.6

1.7

nmol/l

0.1

0.3

2.67

114

(3023410) Appearance of Cerebral spinal fluid

375

2.18

9.76

1.4

2.0

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

111

578

1.94

9.75

1.1

—

(3020630) Protein [Mass/volume] in Serum or Plasma

185

1124

1.67

9.74

1.5

2.1

g/l

66.3

67.6

1.80

167

1056

(3021440) Promyelocytes/100 leukocytes in Blood

319

2201

1.49

9.68

4.3

0.1

0.45

471

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

383

2.16

9.67

1.4

1.7

g/l

0.1

0.5

1.63

355

(3036489) Thrombin time

209

1316

1.62

9.57

3.0

2.5

20.5

20.9

1.10

164

1087

(3017181) Myelocytes/100 leukocytes in Blood

329

2293

1.47

9.49

4.2

0.7

0.8

0.18

509

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

446

2.06

9.48

1.7

1.6

g/l

7.2

7.3

0.17

363

(3015171) Extractable nuclear Ab [Units/volume] in Serum

233

1514

1.57

9.35

1.2

1.3

u/ml

0.2

1.1

—

115

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

429

2.07

9.31

1.4

1.6

g/l

2.9

3.1

0.85

354

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

446

2.04

9.12

1.7

1.6

g/l

3.5

3.7

1.09

339

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

446

2.04

9.12

1.7

1.6

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

355

2.16

8.99

1.2

1.3

—

36.4

—

(3032773) Endomysium IgG Ab [Titer] in Serum

456

2.02

8.95

1.4

1.1

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

330

2.20

8.92

1.4

1.6

g/l

0.0

0.00

313

(3044640) Blood type and Crossmatch panel - Blood

1206

10276

1.24

8.80

2.3

1.9

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

327

2.19

8.71

1.4

1.7

g/l

0.0

0.00

312

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

217

1412

1.56

8.67

1.6

1.7

—

(40768804) Tissue Pathology biopsy report

1423

12364

1.23

8.61

2.0

1.8

—

(3025159) Blasts/100 leukocytes in Blood

303

2119

1.46

8.60

4.4

4.3

0.0

0.2

0.69

406

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

418

2.03

8.44

1.7

1.6

g/l

9.2

10.4

2.23

370

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

368

2677

1.41

8.43

3.6

2.7

34.0

33.1

0.80

287

2060

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

204

1318

1.57

8.42

1.2

1.3

—

(3043409) Potassium [Moles/volume] in Arterial blood

446

1.99

8.41

4.5

3.9

mmol/l

3.8

0.09

410

(3002179) Metamyelocytes/100 leukocytes in Blood

304

2138

1.45

8.38

3.6

4.0

0.4

0.5

0.66

387

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

276

3901

0.69

8.32

1.6

1.8

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

110

604

1.84

8.28

1.5

1.4

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

185

1180

1.59

8.08

1.9

2.1

g/l

1.1

1.2

0.79

178

1125

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

358

2.08

8.04

1.4

1.6

g/l

39.2

39.3

0.08

324

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

129

750

1.74

8.04

6.3

6.6

mg/l

1.2

0.21

115

712

(3044290) Cell count panel - Cerebral spinal fluid

127

740

1.74

7.86

1.2

1.6

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

180

1150

1.59

7.81

1.9

2.1

g/l

0.2

0.28

173

1094

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

324

2342

1.41

7.71

2.3

au/ml

17.1

20.4

0.36

189

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

543

1.84

7.52

1.1

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

917

7695

1.25

7.50

2.3

1.9

—

(3004588) Protein electrophoresis panel - Serum or Plasma

133

799

1.68

7.39

1.6

1.8

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

306

2211

1.41

7.30

3.5

4.0

u/l

210.8

232.3

2.85

282

2108

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

130

780

1.69

7.26

1.1

u/ml

3.7

2.8

0.39

397

(40761535) Cells panel - Urine sediment

272

1926

1.44

7.26

3.4

3.1

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

129

775

1.68

7.18

1.2

1.6

e6/l

13.6

23.1

0.64

101

601

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

129

775

1.68

7.18

1.3

1.6

e6/l

313.3

5454.1

0.56

108

632

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

181

1182

1.55

7.17

5.8

2.9

97.3

94.6

0.88

157

1075

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

277

2.14

6.97

1.7

1.5

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

171

2.47

6.89

1.4

u/l

5.9

0.03

140

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

486

1.85

6.88

1.3

1.2

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

487

1.84

6.84

1.3

1.2

—

(3003338) MCHC [Mass/volume]

3317

31671

1.24

6.75

19.8

11.3

g/l

331.9

332.8

6.92

3294

31385

(40768443) Skin Pathology biopsy report

168

1100

1.55

6.61

1.2

1.1

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

4.01

6.60

1.2

2.4

ng/l

8.8

57.5

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

298

2183

1.39

6.58

1.2

au/ml

18.7

28.3

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

472

1.84

6.57

4.1

2.4

nmol/l

1.0

0.8

0.76

404

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

311

2.04

6.56

1.1

1.2

—

(3017509) Phencyclidine [Presence] in Urine

3.01

6.47

3.6

1.2

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

307

2.03

6.41

1.1

1.2

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

308

2.03

6.36

1.1

1.2

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

309

2.02

6.30

1.1

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

309

2.02

6.30

1.1

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

310

2.01

6.25

1.1

1.2

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

171

1139

1.52

6.24

2.7

2.8

155.5

161.2

0.45

156

1076

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

218

2.21

6.20

1.0

1.1

—

(3051611) Lipemic interference index of Serum or Plasma

206

2.24

6.14

3.3

3.0

—

(4146454)

121

2.65

6.13

3.1

3.0

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

148

962

1.56

6.04

1.9

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

104

620

1.69

6.02

1.3

1.5

—

6.8

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

125

787

1.60

5.86

1.1

1.4

mmol/l

3.6

3.5

0.38

116

739

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

3.40

5.84

1.5

2.9

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

3.40

5.84

1.5

2.9

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

2.79

5.71

6.1

4.4

mg/l

56.4

78.8

1.05

(3050129) First trimester maternal screen panel - Serum or Plasma

468

5776

0.78

5.65

1.5

1.4

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

251

3375

0.73

5.64

1.5

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

3.70

5.63

1.2

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

733

8600

0.82

5.55

1.5

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

136

889

1.55

5.45

1.2

1.3

u/ml

1.9

4.0

—

101

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

136

889

1.55

5.45

1.2

1.5

mg/l

357.9

435.8

2.03

129

847

(3016018) Differential panel - Cerebral spinal fluid

370

1.85

5.40

1.3

1.7

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

180

2.23

5.33

1.0

1.1

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

5.56

5.31

2.2

1.8

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

2.98

5.24

2.2

2.5

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

321

4116

0.76

5.22

1.5

1.6

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

169

2.26

5.21

1.1

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

108

2.60

5.20

2.3

2.4

nmol/l

1.4

1.5

0.13

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

368

1.83

5.18

13.0

6.0

u/ml

0.4

0.12

190

(1002224) Polysomnography panel

182

1278

1.44

5.16

1.1

—

(3004809) Band form neutrophils/100 leukocytes in Blood

298

1.92

5.13

3.1

2.8

1.1

1.3

0.40

232

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

136

902

1.52

5.13

1.2

1.3

u/ml

15.2

12.7

—

147

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

363

1.83

5.09

1.2

1.4

76.1

73.2

1.49

346

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

230

2.05

5.09

1.1

1.3

—

218.8

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

230

2.05

5.09

1.1

1.3

titre

88.6

214.5

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

512

1.69

5.06

2.2

1.9

ug/l

2.2

2.1

0.03

455

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

4.79

5.00

1.5

1.6

nmol/l

369.9

522.9

0.52

(3007463) Buprenorphine [Presence] in Urine

3.89

4.97

8.6

3.9

—

(3000012) Reticulocyte production index

2.73

4.92

1.8

1.3

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

617

1.62

4.90

1.2

umol/l

5.9

6.5

1.16

575

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

571

1.64

4.88

4.4

5.2

iu/ml

348.8

588.1

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

156

1076

1.47

4.88

2.1

2.0

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

325

4123

0.77

4.88

1.5

1.4

—

(3035320) C reactive protein [Mass/volume] in Body fluid

262

1.96

4.85

2.4

2.0

—

(3026389) Candida sp identified in Specimen by Organism specific culture

590

1.62

4.78

1.2

1.3

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

1486

13492

1.16

4.68

1.9

1.8

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

2.71

4.66

1.3

1.6

—

(3049717) Cytology report of Urine Cyto stain

331

1.82

4.62

1.9

2.0

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

2.58

4.62

1.0

1.1

—

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

353

1.79

4.61

1.2

1.4

mu/l

535.6

516.0

0.07

336

(3008116) Ketones [Moles/volume] in Urine by Test strip

3.21

4.60

1.4

1.6

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

310

1.85

4.59

1.4

1.5

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

355

1.78

4.53

1.7

1.4

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

290

1.87

4.53

1.4

1.3

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

107

694

1.55

4.51

1.0

1.1

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

135

2.30

4.50

1.2

1.4

pmol/l

12.8

13.4

0.35

115

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

158

1111

1.44

4.50

1.3

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

356

1.78

4.49

1.7

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

356

1.78

4.49

1.7

1.4

—

(3011985) Renin [Units/volume] in Plasma

320

1.82

4.47

2.1

1.7

mu/l

81.6

78.3

0.03

289

(3048929) Epstein Barr virus Ab [Presence] in Serum

312

2444

1.30

4.47

1.3

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

357

1.77

4.46

1.7

1.4

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

105

2.48

4.44

1.2

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

397

3213

1.26

4.39

1.3

1.4

—

(4010399)

224

1679

1.35

4.38

1.4

1.3

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

2.73

4.33

1.9

2.3

umol/l

22.4

28.5

0.88

(3012898) Urea [Moles/volume] in Urine

4.55

4.29

2.4

2.0

mmol/l

233.6

211.5

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

260

1.89

4.28

2.8

2.9

mg/l

30.8

31.7

0.07

218

(3028433) Virus identified in Specimen by Culture

107

2.44

4.28

1.1

1.2

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

107

2.44

4.28

1.2

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

355

1.76

4.25

1.7

1.4

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

192

2.04

4.21

1.4

1.2

u/l

73.4

85.0

0.19

128

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

364

1.74

4.19

1.7

1.4

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

220

1.96

4.18

1.1

1.0

mg/l

292.6

301.9

0.30

206

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

3.42

4.17

1.2

1.7

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

164

1179

1.41

4.15

5.6

3.0

g/l

3.7

3.6

0.35

147

1110

(3006184) Hemoglobin [Mass/volume] in Capillary blood

518

1.61

4.14

2.6

2.2

g/l

132.6

131.3

0.28

413

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

120

814

1.49

4.14

1.1

1.3

u/ml

36.2

35.9

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

278

1.84

4.12

1.4

1.2

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

153

1090

1.42

4.09

1.2

1.1

—

(3044242) Glucose [Moles/volume] in Arterial blood

2.71

4.07

1.6

3.0

—

(4306422)

101

663

1.53

4.07

1.1

1.2

—

(3030313) Adrenal Ab [Titer] in Serum

2.63

4.05

1.3

1.0

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

324

1.77

4.02

1.4

1.3

nmol/l

0.5

0.03

313

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

430

1.66

4.00

2.8

2.6

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

260

1.85

3.96

2.9

mg/l

121.3

25.6

0.56

217

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.53

3.95

1.1

—

(3000093) Morphology [Interpretation] in Blood Narrative

204

1.97

3.95

1.0

1.1

—

(3032057) Clostridioides difficile [Presence] in Stool

3.64

3.91

1.8

2.0

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

161

1167

1.39

3.91

1.8

2.2

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

158

1143

1.40

3.88

1.6

2.0

u/l

39.7

39.0

0.16

141

1075

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

262

1.84

3.88

2.0

1.4

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

224

1718

1.32

3.79

2.7

2.2

ml/min/173m2

83.1

84.2

0.18

624

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

1261

0.65

3.73

1.6

mmol/l

7.1

7.4

0.66

771

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

183

1.97

3.61

1.1

1.3

g/l

0.3

1.29

142

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

255

1.81

3.57

1.2

1.1

—

(3006270) Folate [Moles/volume] in Blood

212

1.89

3.56

1.3

1.1

nmol/l

443.3

415.1

0.44

204

(3017354) Segmented neutrophils/100 leukocytes in Blood

192

1.93

3.51

2.4

61.0

54.1

1.32

124

(3030981) Hyaline casts [#/volume] in Urine by Automated count

164

1216

1.36

3.50

3.1

2.4

e6/l

0.3

0.2

0.63

157

1158

(3004616) Nuclear Ab [Presence] in Serum

377

1.65

3.49

1.3

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

347

1.68

3.47

1.0

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

222

1.85

3.43

1.0

1.1

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

144

1050

1.38

3.42

1.4

1.3

u/ml

221.4

237.5

0.38

640

(40760888) Immunoglobulin light chains.free panel - Serum

194

1.91

3.41

2.4

3.1

—

(3051651) Icteric interference index of Serum or Plasma

153

2.03

3.39

3.2

3.4

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

226

1.82

3.26

1.0

1.1

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

681

1.46

3.26

1.4

1.2

u/ml

5.2

4.4

0.20

307

(3008757) Leukocyte morphology finding [Identifier] in Blood

227

1.81

3.22

3.3

3.1

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

150

2.00

3.18

3.8

2.7

umol/l

59.2

50.6

0.61

133

(3024980) IgG subclass 4 [Mass/volume] in Serum

538

1.51

3.17

1.4

1.6

g/l

0.6

0.02

410

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

151

1.99

3.13

1.3

1.6

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

297

1.69

3.10

1.3

1.5

pmol/l

504.3

476.8

0.14

235

(3041806) Other cells [#/volume] in Blood by Manual count

601

1.47

3.03

1.5

—

(3036180) Methadone [Presence] in Urine

5.83

3.01

1.3

3.0

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

637

1.45

2.96

1.1

113.8

116.9

0.51

569

(3006922) Hepatitis E virus Ab [Presence] in Serum

242

1.74

2.92

1.0

1.1

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

396

1.57

2.92

1.1

1.3

—

283.3

—

(3029937) Albumin [Presence] in Urine by Test strip

1047

9533

1.13

2.91

4.2

3.2

estimate

0.0

2.55

403

3772

(3028679) Herpes simplex virus Ab [Presence] in Serum

350

1.61

2.89

1.2

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

2.93

2.85

2.3

5.9

—

(3040151) Glucose [Moles/volume] in Capillary blood

291

1.66

2.80

2.9

5.4

mmol/l

6.5

6.3

0.14

228

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

4.45

2.79

6.8

5.8

mmol/l

3.7

6.2

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

514

1.49

2.77

1.3

1.1

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

706

1.41

2.74

1.7

2.1

mg/l

10.4

9.6

0.67

673

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

2.86

2.74

1.3

1.1

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

168

1302

1.30

2.73

1.3

—

(3025130) Human papilloma virus identified in Specimen

134

1006

1.34

2.72

1.9

1.7

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

2.50

2.69

1.3

1.8

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

189

1.80

2.69

1.4

1.6

nmol/l

1.1

2.7

0.84

147

(3013336) Amino acids [Identifier] in Serum or Plasma

4.21

2.67

1.5

3.1

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

243

1.69

2.62

1.4

1.2

—

(40757494) Bilirubin.total [Moles/volume] in Blood

100

2.10

2.57

2.1

umol/l

14.0

26.2

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

129

972

1.34

2.57

1.5

1.4

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

275

1.64

2.57

1.3

1.6

—

(3047181) Lactate [Moles/volume] in Blood

623

1.42

2.56

5.0

5.6

mmol/l

1.2

1.1

0.50

543

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

346

1.57

2.55

1.1

g/l

1.5

1.4

0.42

318

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

7.14

2.54

1.4

1.1

—

(3000034) Microalbumin [Mass/volume] in Urine

149

1.88

2.54

3.4

3.1

mg/l

36.6

60.0

0.44

110

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

122

1.97

2.49

2.2

1.6

u/l

5.1

3.8

0.23

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

3.46

2.47

1.0

1.1

—

(3025315) Body weight

4.38

2.47

3.1

2.2

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

874

0.67

2.46

1.5

1.6

mmol/l

6.3

6.6

0.46

608

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

248

2988

0.82

2.45

1.3

—

(44806071)

2.38

2.45

1.1

—

(3037756) Immunofixation for Serum or Plasma

166

1.81

2.43

1.9

1.5

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

605

1.41

2.42

2.1

1.5

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

367

1.53

2.41

1.8

1.6

—

(3035285) Chloride [Moles/volume] in Venous blood

145

1.87

2.40

2.0

2.1

mmol/l

104.7

106.2

0.72

145

(3041354) Potassium [Moles/volume] in Venous blood

145

1.87

2.40

2.0

2.1

mmol/l

3.7

3.9

1.54

145

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

2.21

2.36

1.2

1.4

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

282

1.60

2.35

2.0

1.5

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

372

0.51

2.35

1.2

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

122

927

1.32

2.33

1.5

1.4

u/ml

97.4

105.2

0.46

182

(3034274) Bile acid [Moles/volume] in Serum --fasting

220

1802

1.23

2.30

2.0

2.4

umol/l

5.8

5.3

0.13

159

1335

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

133

1.88

2.30

1.4

1.1

—

(3028717) Thiamine [Mass/volume] in Blood

2.86

2.30

1.2

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

2.12

2.27

1.0

1.1

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

2.55

2.26

1.2

1.1

umol/24h

0.8

0.6

—

(3037121) Protein [Mass/volume] in Urine

125

959

1.31

2.24

2.4

3.6

g/l

0.2

0.4

1.42

446

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

318

1.55

2.23

1.4

1.2

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

319

1.54

2.20

1.4

1.2

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

705

7756

0.89

2.17

1.6

1.5

—

(3005322) IgE [Units/volume] in Serum or Plasma

343

2949

1.18

2.16

1.3

u/ml

237.6

213.9

0.15

321

2728

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

611

1.38

2.15

1.2

1.1

iu/ml

108.3

2501.2

0.92

193

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

705

1.35

2.15

1.4

1.2

u/ml

3.8

3.9

0.02

260

(3017732) Neutrophils [#/volume] in Blood

279

2358

1.20

2.14

2.4

2.0

e9/l

3.8

4.3

2.49

204

1997

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

159

1.76

2.12

2.1

1.6

—

(3022689) Creatine [Moles/volume] in Urine

2.37

2.11

1.5

1.8

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

2.05

2.10

1.2

1.3

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

2.05

2.10

1.2

1.3

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

339

1.51

2.10

1.2

1.8

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

2.56

2.09

1.2

1.0

—

(3005011) Chlamydia sp Ab [Titer] in Serum

2.14

2.07

1.6

1.5

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

198

1.67

2.07

1.1

nmol/l

0.1

4.9

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1463

13777

1.09

2.05

3.8

3.0

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

2.05

2.00

1.4

u/l

9.5

11.7

1.41

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

384

1.46

2.00

1.2

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

163

2002

0.81

1.99

2.0

2.2

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

126

1.83

1.97

1.7

1.2

—

(3001556) Androgen free Index in Serum or Plasma

134

1.79

1.94

1.3

1.1

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

4.54

1.94

1.0

1.1

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

184

2217

0.82

1.88

1.2

—

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

2.31

1.87

1.9

1.6

mg/l

2.5

4.4

—

(1617658) Protocol used for examination of sentinel lymph nodes

197

0.46

1.83

1.0

1.1

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

2.57

1.79

1.0

1.2

—

(3051593) INR in Capillary blood by Coagulation assay

2.57

1.79

1.6

4.4

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

1.92

1.79

1.3

—

18.6

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

336

1.46

1.78

1.1

ratio

1.0

0.04

131

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

153

0.39

1.75

1.7

1.3

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

216

1.58

1.75

1.1

1.4

u/l

36.4

30.2

0.09

181

(3041096) Erythrocytes [Presence] in Urine by Automated

1125

10536

1.09

1.75

3.3

2.6

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

297

1.48

1.73

1.6

1.2

—

(3017569) Oxygen content in Arterial blood

2.22

1.73

2.1

3.5

—

(4062490)

364

1.43

1.71

1.3

1.5

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

140

1.72

1.71

2.1

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

2.06

1.69

2.8

3.2

nmol/l

1.1

0.8

—

(3008898) HLA-B27 [Presence]

240

2051

1.18

1.68

1.1

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

383

1.41

1.66

2.3

2.7

ug/min

56.5

113.4

0.94

262

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

3.16

1.66

1.7

2.4

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

1.89

1.64

1.4

1.1

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

402

1.40

1.62

2.7

4.1

u/ml

38.2

88.4

—

129

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

261

1.50

1.62

1.4

1.6

—

(3029075) Extractable nuclear Ab panel - Serum

128

1.72

1.59

1.0

1.1

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

140

1144

1.23

1.59

1.7

2.2

iu/l

2.2

4.2

8.92

479

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

238

1.52

1.58

2.0

1.6

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

3.00

1.58

1.0

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

263

1.49

1.57

1.8

2.6

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

255

1.49

1.56

1.1

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

440

1.37

1.54

1.1

83.0

92.4

1.76

406

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

406

1.38

1.54

1.1

1.2

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

137

1.68

1.54

2.0

1.4

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

2.42

1.53

2.9

3.8

—

(3038026) Centromere Ab [Units/volume] in Serum

224

1.52

1.53

1.1

1.3

—

42.5

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1469

13975

1.08

1.53

1.9

1.8

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

143

0.42

1.51

1.0

1.1

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

2.86

1.50

1.0

1.1

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

643

1.30

1.49

2.8

3.7

56.9

56.5

0.09

643

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

178

1.58

1.47

1.8

1.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

178

1.58

1.47

1.7

1.6

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

178

1.58

1.47

1.8

1.6

—

(1761482) Bacteria [#/volume] in Urine by Culture

436

1.36

1.46

3.6

3.0

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

1179

0.79

1.46

1.5

—

(3017704) Immunofixation for Urine

2.22

1.46

1.8

1.4

—

(40761536) Microorganisms panel - Urine sediment

390

3493

1.13

1.46

4.0

3.1

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

663

1.29

1.45

1.2

1.1

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

236

2044

1.16

1.44

1.3

ug/l

3.8

0.05

228

1947

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

3.12

1.43

1.8

1.1

—

(3000492) Spirometry study

353

3147

1.13

1.42

1.4

1.3

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

118

1.70

1.40

1.0

1.1

iu/ml

—

4.2

—

(3042733) HLA Ab [Presence] in Serum

1.89

1.38

5.5

4.1

—

(3030905) Polymorphonuclear cells [#/volume] in Blood

633

1.28

1.38

2.7

3.5

e9/l

4.2

4.0

0.34

633

(3027135) IgG subclass 1 [Mass/volume] in Serum

364

1.38

1.37

1.2

1.4

g/l

6.0

6.4

0.52

257

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

150

1.60

1.37

1.0

1.1

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

174

1.55

1.36

1.1

—

(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid

2.94

1.35

1.0

—

(21494815) CD4 cells/100 lymphocytes in Specimen

289

1.42

1.35

2.0

2.5

45.3

47.9

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

0.00

1.34

0.0

1.8

—

0.9

—

(3002619) Bacteria identified in Specimen by Culture

1.87

1.33

1.1

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

2.50

1.30

1.0

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

2.50

1.30

1.7

1.1

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

242

1.45

1.29

1.8

1.6

—

(3045424) Erythrocytes [Presence] in Urine

526

1.30

1.27

1.7

1.4

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

2.08

1.27

1.0

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

310

1.39

1.27

1.7

1.4

—

(3000060) B lymphocytes [#/volume] in Blood

162

1.54

1.25

1.8

2.7

e6/l

314.1

196.4

0.62

(21494890) Protein electrophoresis panel - 24 hour Urine

1.74

1.24

2.2

2.0

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

2.40

1.24

1.0

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

363

1.35

1.23

1.2

1.4

g/l

0.3

0.4

1.76

254

(3028192) IgG subclass 2 [Mass/volume] in Serum

363

1.35

1.23

1.2

1.4

g/l

2.9

0.01

253

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

2.00

1.23

1.1

1.2

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

1.77

1.22

2.3

1.6

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

1.96

1.21

1.3

1.1

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

2.04

1.21

1.0

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

221

1.45

1.20

1.0

1.1

—

(3011412) CD3 cells [#/volume] in Blood

348

1.35

1.20

1.8

2.8

e9/l

1.5

1.3

0.66

203

(3001964) Herpes simplex virus Ag [Presence] in Specimen

101

1.68

1.19

1.3

1.4

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.74

1.18

1.0

1.1

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

149

1.54

1.16

1.2

1.1

—

(3024471) HLA-A [Type]

1.77

1.16

1.1

1.0

—

(3024932) HLA-DR beta [Type]

1.77

1.16

1.2

1.1

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

118

1.61

1.14

3.2

4.3

—

(3036071) Salmonella sp Ab [Titer] in Serum

158

1.52

1.14

1.1

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1754

16922

1.06

1.14

4.2

4.0

—

(3001019) Free T4 and TSH panel - Serum or Plasma

284

3159

0.89

1.12

1.5

1.6

—

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

2.00

1.12

5.8

6.8

mg/l

1.8

3.0

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

273

2441

1.13

1.10

1.4

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

556

1.26

1.10

1.8

1.5

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.26

1.10

1.0

1.1

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

285

1.37

1.09

1.3

1.2

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

673

1.24

1.09

1.4

1.2

—

(4034850)

100

827

1.21

1.09

8.9

6.8

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.73

1.08

1.0

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

162

0.55

1.08

1.0

1.2

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

2.19

1.08

1.0

1.1

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

1.69

1.07

2.3

1.6

—

(3036048) Francisella tularensis Ab [Titer] in Serum

1.76

1.06

1.2

1.1

—

176.0

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

287

1.36

1.06

1.8

2.8

e6/l

597.4

514.4

0.73

236

(3034988) Calcium [Moles/volume] in Capillary blood

1.92

1.05

3.6

1.9

mmol/l

1.2

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

105

1.62

1.05

2.2

1.8

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

105

1.62

1.05

2.2

1.8

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

105

1.62

1.05

2.2

1.8

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

105

1.62

1.05

2.2

1.8

—

(44813793)

401

1.30

1.04

1.1

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

179

1.45

1.02

1.2

1.1

u/ml

3.2

10.3

0.57

124

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

627

1.23

1.00

1.2

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

1.84

0.98

2.2

1.2

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

258

1.36

0.96

1.9

2.9

e6/l

880.7

896.6

0.04

102

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

284

1.34

0.95

1.8

2.8

e9/l

0.2

0.06

237

(40768795) Lymph node Pathology biopsy report

210

0.62

0.95

1.5

1.2

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.89

0.94

1.0

1.1

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

1.89

0.94

22.9

6.0

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

242

1.36

0.94

1.2

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

286

1.33

0.92

1.3

1.4

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

1.73

0.92

1.3

1.6

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1166

11178

1.06

0.91

1.6

1.5

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

2.14

0.91

1.0

1.1

umol/24h

1.6

1.5

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

1013

0.83

0.90

1.7

1.9

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

331

1.30

0.90

2.3

2.2

u/ml

13.6

6.3

0.52

254

(3011841) English Walnut IgE Ab [Units/volume] in Serum

102

1.57

0.90

1.0

u/ml

0.0

1.9

1.14

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

288

1.32

0.89

1.7

2.5

9.4

10.9

0.56

175

(40768441) Liver Pathology biopsy report

185

1.41

0.88

1.1

1.5

—

(3047189) Immunofixation for 24 hour Urine

1.90

0.88

1.4

1.6

—

(40768806) Pleura Pathology biopsy report

1.69

0.88

1.2

1.4

—

(3023199) Leukocytes [#/volume] in Pleural fluid

1.61

0.87

1.3

1.4

e6/l

1344.1

3389.0

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

712

1.20

0.86

1.2

1.1

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

1.72

0.85

1.0

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

308

1.30

0.84

1.1

iu/ml

6.1

5.1

0.10

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

120

1.50

0.84

1.1

1.0

—

(3036312) Salmon IgE Ab [Units/volume] in Serum

1.78

0.84

1.1

u/ml

2.0

0.5

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

137

1198

1.15

0.83

1.2

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

179

1.40

0.83

1.2

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

114

0.52

0.82

3.7

2.7

—

(3021788) Differential panel - Synovial fluid

336

1.28

0.82

1.9

1.6

—

(3035933) Granulocytes/100 leukocytes in Blood

171

1.40

0.82

1.3

1.9

—

(1761868) Lipid panel - Serum or Plasma

1165

12080

0.95

0.82

2.2

2.0

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1.55

0.81

2.3

1.5

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

553

1.21

0.81

1.9

1.6

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

1.57

0.80

1.1

—

(3045414) Leukocytes [Presence] in Urine

168

1494

1.13

0.80

2.0

1.7

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

718

0.82

0.80

1.3

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

400

1.25

0.80

1.4

—

(3026250) Tacrolimus [Mass/volume] in Blood

122

1.48

0.79

55.4

34.2

ug/l

7.6

7.0

0.54

111

(3027035) Albumin [Mass/time] in 24 hour Urine

0.00

0.79

0.0

1.2

—

57.9

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

0.00

0.79

0.0

1.0

—

(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence

0.00

0.79

0.0

1.1

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

149

1317

1.13

0.79

1.5

1.4

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

437

1.24

0.78

1.1

1.0

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

233

1.33

0.78

1.2

1.1

u/ml

219.8

13.7

0.46

149

(3014271) Vancomycin [Susceptibility]

1.67

0.78

2.1

2.0

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

0.00

0.78

0.0

1.2

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

1.69

0.75

1.4

1.2

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

2.08

0.74

2.4

1.3

nmol/l

72.4

16.7

—

(3039443) Prostate specific Ag panel - Serum or Plasma

107

0.56

0.72

1.5

—

(4268621)

488

1.21

0.72

2.6

2.2

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

1.52

0.72

2.0

2.3

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

1.67

0.71

1.7

1.2

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

1.55

0.71

1.0

1.1

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

1.75

0.71

1.0

1.3

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

1.53

0.68

1.0

1.1

—

(3034426) Prothrombin time (PT)

135

1.41

0.68

1.3

1.2

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

382

1.23

0.68

2.0

2.6

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

110

1.45

0.68

1.1

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

170

1.35

0.67

1.9

2.7

mg/l

10.2

9.8

0.12

142

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

258

1.28

0.66

1.6

1.7

mg/l

31.9

24.7

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

188

1.33

0.65

2.2

1.9

—

(3029396) Erythrocyte agglutination [Presence] in Blood

405

0.79

0.65

3.4

3.2

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

1.54

0.65

1.3

1.4

e6/l

10234.2

49185.7

—

(3012441) Differential panel - Pleural fluid

1.54

0.65

1.3

1.4

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

215

1.30

0.64

1.0

1.1

83.6

99.1

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

451

4765

0.94

0.63

1.5

—

(3002256) Pathology report gross observation

384

3605

1.07

0.62

1.2

—

(3003694) ABO and Rh group [Type] in Blood

1441

14777

0.96

0.62

1.8

1.9

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

1.63

0.62

2.1

1.3

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

1.63

0.62

1.4

3.1

—

10.2

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

290

0.76

0.61

1.0

1.1

miu/ml

1986.1

1461.3

1.10

290

(3000330) Specific gravity of Urine by Test strip

135

1210

1.12

0.61

3.1

2.5

—

(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum

1.67

0.61

1.0

1.2

—

(4281824)

256

0.74

0.61

1.2

1.1

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

113

1.42

0.60

1.0

u/ml

0.0

0.1

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

1.48

0.60

1.3

2.4

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

1.48

0.60

1.3

2.4

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

0.00

0.59

0.0

4.0

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

0.00

0.59

0.0

3.9

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

355

0.79

0.59

2.8

3.7

u/ml

18.3

24.3

0.70

341

(3015076) Soybean IgE Ab [Units/volume] in Serum

410

0.80

0.59

1.0

1.1

u/ml

0.3

1.8

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

1.44

0.58

1.3

1.1

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

0.00

0.58

0.0

3.2

—

2.3

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

1.71

0.57

24.3

6.2

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

401

1.20

0.56

1.0

1.1

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

792

1.14

0.56

1.2

1.1

au/ml

15.7

10.5

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

1.45

0.56

1.1

1.3

—

(3015183) Erythrocyte sedimentation rate

284

0.77

0.54

1.2

—

(3023419) Bacteria identified in Sputum by Culture

168

1.31

0.54

2.5

3.2

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.58

0.54

1.0

1.1

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

195

2109

0.92

0.54

1.5

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

221

2048

1.08

0.53

1.6

2.2

u/ml

21.1

32.1

3.08

214

1974

(3013637) Mi-2 Ab [Presence] in Serum

1.51

0.52

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

1.51

0.52

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

1.51

0.52

1.1

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

1.51

0.52

2.7

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

1.51

0.52

1.1

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

435

0.83

0.52

1.0

1.1

u/ml

47.1

2.3

0.45

138

(3051387) C reactive protein [Mass/volume] in Capillary blood

620

1.15

0.51

3.9

3.0

mg/l

17.9

24.0

0.77

385

(3003740) Influenza virus B Ag [Presence] in Specimen

105

941

1.12

0.51

1.1

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

188

1.28

0.50

1.3

1.2

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

109

1207

0.90

0.50

1.8

1.6

iu/ml

0.0

0.3

2.05

215

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

153

1.31

0.49

1.1

1.2

—

(3002523) Influenza virus A Ag [Presence] in Specimen

105

943

1.12

0.49

1.1

—

(3019832) Treponema pallidum Ab [Presence] in Serum

1336

13029

1.04

0.49

1.9

1.7

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

1.43

0.49

1.0

1.1

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

1.55

0.48

2.6

2.9

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

119

1.34

0.47

1.1

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

1.49

0.47

1.3

1.0

—

(3043410) Blood group antigens tested for on Red Blood Cells

102

1.37

0.47

1.4

—

(3004451) EKG impression Narrative

1.46

0.46

1.3

1.2

—

(3010375) cycloSPORINE [Mass/volume] in Blood

120

1.33

0.45

24.8

27.8

ug/l

156.9

131.5

0.35

103

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

311

2940

1.06

0.45

1.4

1.3

miu/ml

202.5

238.7

1.04

134

1524

(3014051) Protein [Presence] in Urine by Test strip

769

1.12

0.45

2.3

1.8

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

1.39

0.44

2.6

1.9

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

1.39

0.44

2.6

1.9

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

376

1.17

0.43

1.0

1.4

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

247

1.21

0.43

1.7

1.4

—

(3008536) Aspergillus sp Ab [Presence] in Serum

1.61

0.43

1.2

2.2

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

396

1.16

0.42

1.2

1.3

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

0.64

0.42

1.0

1.4

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

1.40

0.42

1.1

1.0

—

(3044941) Cell count panel - Synovial fluid

276

1.20

0.41

1.6

1.4

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

1.43

0.41

7.0

3.5

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

1.38

0.41

1.1

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

0.41

0.0

1.3

—

(3051101) Glucose [Moles/volume] in Cord blood

0.00

0.41

0.0

3.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

421

4387

0.95

0.40

1.5

1.4

—

(3018834) Bilirubin.total [Presence] in Urine by Test strip

0.00

0.40

0.0

2.0

—

(3014891) Appearance of Pleural fluid

0.00

0.40

0.0

1.6

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

424

4417

0.95

0.40

1.5

1.4

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

0.00

0.40

0.0

5.2

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

424

4413

0.95

0.39

1.5

1.4

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.31

0.39

1.1

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

1.43

0.39

1.2

4.3

umol/l

47.8

45.3

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

1.43

0.39

1.0

1.2

—

(3044927) Protein electrophoresis panel - Urine

1.34

0.39

1.2

1.1

—

(3020491) Glucose [Moles/volume] in Blood

306

1.18

0.39

1.7

mmol/l

5.2

5.7

1.67

260

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

424

4407

0.96

0.37

1.5

1.4

—

(4027681)

354

1.16

0.37

1.3

1.2

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

1.35

0.37

2.7

1.9

—

(40768793) Breast Pathology biopsy report

746

0.90

0.37

1.2

1.3

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

1.33

0.37

1.0

u/ml

0.5

0.0

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

225

1.20

0.36

1.0

1.1

92.0

98.2

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

1.36

0.36

1.2

1.5

ug/l

10.7

8.1

0.56

(4024509)

277

0.83

0.35

2.0

1.4

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

1.43

0.35

1.2

1.1

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

441

1.13

0.35

1.2

1.3

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

123

0.73

0.35

1.0

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

123

0.73

0.35

1.0

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

123

0.73

0.35

1.0

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1.36

0.34

6.2

6.3

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

283

1.17

0.33

1.0

1.1

u/l

1.1

1.0

—

115

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

100

1.30

0.33

1.1

1.0

u/ml

0.2

0.1

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

691

1.10

0.33

1.3

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

191

1.20

0.33

4.2

2.3

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

903

1.09

0.32

1.2

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

116

1245

0.93

0.32

2.5

3.6

ug/l

28.5

45.4

0.17

853

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

506

0.89

0.31

1.4

1.8

—

(3020393) Adenovirus Ag [Presence] in Stool

1.30

0.30

1.6

—

(3000475) Leukocytes [#/volume] in Synovial fluid

400

1.13

0.29

2.0

1.7

e6/l

23307.0

8539.9

0.79

299

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

166

1.20

0.29

1.8

3.0

42.3

45.1

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

100

928

1.08

0.29

1.1

—

(3032868) Hemoglobin electrophoresis panel in Blood

1.23

0.29

1.3

1.6

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

216

0.83

0.28

1.4

1.3

g/l

0.9

0.07

216

(3043238) Trisomy 21 risk [Likelihood] in Fetus

371

3580

1.04

0.28

1.5

—

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

103

1.26

0.28

1.0

u/ml

0.1

1.8

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

195

1.18

0.28

1.6

1.5

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

132

1242

1.06

0.27

3.7

3.5

ug/l

1.4

1.9

1.12

110

1117

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

432

1.11

0.27

1.2

1.1

mg/l

34.1

35.4

0.05

350

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

113

1.24

0.26

1.0

1.1

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

215

1.16

0.26

1.4

1.2

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

104

1.25

0.26

2.0

3.2

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

224

0.85

0.25

1.1

1.0

—

(3045788) Cell count panel - Pleural fluid

1.23

0.25

1.3

1.5

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

1.23

0.25

1.7

2.4

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

961

0.93

0.24

3.7

3.3

20.9

21.9

0.16

354

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

1.26

0.24

1.0

u/ml

0.0

0.5

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

361

3496

1.03

0.24

1.5

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

426

1.10

0.24

1.7

1.5

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

169

0.83

0.24

1.9

u/field

2.4

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

702

0.92

0.23

2.5

2.4

ug/l

0.5

0.7

2.72

378

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

228

1.14

0.22

1.5

1.2

—

(3012565) Volume of 24 hour Urine

116

1.21

0.21

1.6

2.0

1933.3

1924.2

—

109

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.21

0.0

1.0

—

(3007919) Fasciola sp Ab [Titer] in Serum

0.00

0.21

0.0

1.0

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

0.00

0.21

0.0

2.9

—

(4038314)

0.00

0.21

0.0

1.2

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

0.21

0.0

1.0

—

(3015147) Influenza virus A IgG Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

0.00

0.21

0.0

1.0

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

2.3

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.21

0.0

1.0

—

(3020934) Sesame Seed IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

0.6

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

0.00

0.21

0.0

1.2

—

(40758358) Immune stain study

0.00

0.21

0.0

1.0

—

(4035726)

162

1690

0.96

0.21

1.4

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

3323

33055

1.02

0.21

4.4

4.2

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

0.00

0.21

0.0

1.1

—

30.2

—

(3004269) Kappa light chains [Mass/time] in 24 hour Urine

0.00

0.21

0.0

2.5

—

(3042631) Mycobacterium sp identified in Specimen

126

1.19

0.20

2.1

2.7

—

(3005033) Fetal Nuchal fold Thickness US

359

3490

1.03

0.20

1.5

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

1.20

0.19

1.8

1.5

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

376

1.09

0.18

1.1

—

(4211845)

204

1.13

0.17

2.3

2.1

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

775

1.06

0.17

2.7

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

0.75

0.17

6.2

4.3

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

183

0.87

0.16

6.8

7.4

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

818

1.05

0.15

1.4

nmol/l

32.6

32.3

0.02

750

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

274

1.09

0.15

1.9

1.4

—

(3024263) Appearance of Synovial fluid

1.10

0.15

1.6

2.5

—

(3022621) pH of Urine by Test strip

222

2160

1.03

0.14

2.5

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

315

1.08

0.13

1.2

1.3

u/ml

0.5

0.3

0.27

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

113

1.15

0.13

1.0

1.2

—

(3020874) Milk IgE Ab [Units/volume] in Serum

432

1.06

0.13

1.0

1.1

u/ml

0.4

2.9

2.21

166

(44790048)

324

0.92

0.12

1.3

1.5

—

(44790049)

324

0.92

0.12

1.3

1.5

—

(44806118)

324

0.92

0.12

1.3

1.5

—

(44790047)

324

0.92

0.12

1.3

1.5

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

188

0.90

0.11

1.1

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

299

1.07

0.10

1.6

1.9

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.11

0.09

1.0

1.1

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

419

1.05

0.08

1.1

mg/l

203.1

200.9

0.02

361

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

1.05

0.07

1.0

1.1

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

128

1252

1.02

0.07

1.1

u/ml

1.0

1.2

0.27

597

(3003888) Timothy IgE Ab [Units/volume] in Serum

136

1333

1.02

0.06

1.1

u/ml

6.0

6.7

0.18

793

(3010726) Horse dander IgE Ab [Units/volume] in Serum

132

1296

1.02

0.05

1.1

u/ml

1.4

2.8

1.01

367

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

178

1.07

0.05

1.6

2.4

ug/l

21.9

175.9

0.72

164

(3023430) Cat dander IgE Ab [Units/volume] in Serum

101

989

1.02

0.05

1.1

u/ml

4.3

7.5

0.84

459

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

189

1.06

0.04

1.1

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

583

0.98

0.04

1.2

—

(40765089) Chromosome analysis panel - Blood by G-banded

321

0.96

0.04

1.0

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

148

1496

0.99

0.04

1.2

1.1

u/ml

0.9

2.0

2.35

666

(21494814) CD8 cells/100 lymphocytes in Specimen

111

1.08

0.03

1.7

2.3

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

646

1.02

0.03

1.5

mmol/l

11.6

11.0

0.18

(3009871) Measles virus Ab [Titer] in Serum

108

0.92

0.03

2.0

1.8

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

450

0.98

0.03

3.1

3.2

u/ml

83.2

392.4

0.49

377

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

390

1.02

0.02

1.8

1.4

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

110

1089

1.01

0.01

1.1

u/ml

3.9

5.7

0.34

464

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

187

0.96

0.01

1.1

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

133

1.05

0.01

1.0

1.1

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

126

0.95

0.01

1.0

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

846

0.99

0.01

1.1

u/ml

0.1

0.3

1.11

204

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

323

0.99

0.00

1.7

1.4

—

(40768446) Kidney Pathology biopsy report

100

1.00

0.00

2.2

1.5

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

119

1.01

0.00

1.2

1.1

—

(3020650) Glucose [Presence] in Urine

129

1.01

0.00

1.6

1.4

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

234

0.98

0.00

2.5

1.7

58.1

46.4

0.66

150

(21494434) Karyotype in Bone marrow

116

1.03

0.00

1.0

1.2

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

591

5908

1.00

0.00

2.2

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

227

1.01

0.00

3.8

3.7

mg/l

7.7

7.9

0.04

189

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

336

1.01

0.00

2.4

1.9

—

(4094501)

381

1.00

0.00

1.0

—

(3045142) Bone marrow Pathology biopsy report

155

1.03

0.00

1.1

1.4

—

(3006462) Nitrate [Presence] in Urine

186

1.02

0.00

2.5

2.1

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

111

0.99

0.00

2.4

1.5

—

(3003771) Antithrombin Ag actual/normal in Platelet poor plasma by Immunoassay

0.00

0.0

1.3

—

94.9

—

(3032641) Amino acids panel - Urine

0.00

0.0

1.5

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3021691) Plasmodium malariae Ab [Titer] in Serum

0.00

0.0

3.0

—

(3016135) IgD [Mass/volume] in Serum

0.00

0.0

1.4

—

98.3

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence

0.00

0.0

1.1

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

0.00

0.0

1.0

—

(3012989) Citrate [Moles/time] in 24 hour Urine

0.00

0.0

1.7

—

2.7

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.0

1.0

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

0.94

0.00

1.0

1.3

—

(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method

0.00

0.0

1.0

—

(3015350) Toxocara sp Ab [Presence] in Serum

0.00

0.0

1.0

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

0.00

0.0

13.6

—

(3001218) Citrate [Mass/time] in 24 hour Urine

0.00

0.0

1.6

—

(3041184) Isoniazid [Presence] in Urine

0.00

0.0

2.2

—

(3027859) Formaldehyde IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3013293) Extractable nuclear Ab [Presence] in Serum

0.98

0.00

1.2

1.8

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

0.95

0.00

1.3

1.1

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

0.0

1.2

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

0.00

0.0

4.0

—

503.8

—

(3017894) Mustard IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

0.4

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

1.02

0.00

1.0

1.1

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

0.00

0.0

1.2

—

(3010937) Rubella virus Ab [Presence] in Serum

1.01

0.00

1.1

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

0.00

0.0

1.0

—

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

0.00

0.0

1.4

—

1.4

—

(3002853) Influenza virus B Ab [Titer] in Serum

0.00

0.0

1.0

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

1.00

0.00

1.1

1.0

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

0.91

0.00

1.0

1.1

—

(40760512) CD34 cells/100 cells in Bone marrow

0.00

0.0

1.4

—

(3002079) Sodium [Moles/time] in 24 hour Urine

0.00

0.0

1.1

—

119.0

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

0.00

0.0

1.0

—

1.3

—

(3038385) Creatinine [Moles/volume] in Peritoneal fluid

0.00

0.0

1.2

—

175.0

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

0.00

0.0

1.2

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

0.00

0.0

2.4

—

(40758292) HTLV I+II Ab panel - Serum

0.94

0.00

1.0

1.3

—

(3042934) Triiodothyronine (T3) Ab [Presence] in Serum

0.00

0.0

1.0

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

0.00

0.0

1.0

—

(3001729) Color of Synovial fluid

0.00

0.0

1.6

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: KRA_PSY_EATING – Eating disorder

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Eating disorder

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Eating disorder (KRA_PSY_EATING)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints